Recall events
/
Event 65707
Event summary
Timeline bucket July 02, 2013
Product types Drug
Classifications Class II
Statuses Terminated
Recalling firm wording Aidapak Services, LLC
Dossier provenance
Source snapshots represented here
openFDA Drug Enforcement
Report-date coverage
June 20, 2012–July 08, 2026
Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.
Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.
How coverage and grouping work
Device root-cause evidence is not applicable to this event.
No grouped product has the official product type device; this is not an unavailable-enrichment finding.
Complete imported group
Every recalled product in this event
273 official enforcement rows
Product dates, classifications, firms, and source wording remain attached to their individual rows.
Opening this dossier never hides products that did not match a prior timeline filter.
drug · product 1 of 273
ZINC GLUCONATE, Tablet, 50 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00904319160.
D-463-2014
Recall number D-463-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 200 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
Labeling: Label Mixup
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; ZINC GLUCONATE, Tablet, 50 mg may be potentially mis-labeled as ASCORBIC ACID, Chew Tablet, 500 mg, NDC 00904052660, Pedigree: AD60240_54, EXP: 5/22/2014 and ASCORBIC ACID, Chew Tablet, 250 mg, NDC 00904052260, Pedigree: W003027, EXP: 6/12/2014.
Code information ZINC GLUCONATE, Tablet, 50 mg has the following codes: Pedigree: AD60240_57, EXP: 5/22/2014; Pedigree: W003028, EXP: 6/12/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[3884]
FDA event record
· Exact recall-number query on openFDA
drug · product 2 of 273
CALCIUM CARBONATE +D3, Tablet, 600 mg/400 units, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00904323392.
D-464-2014
Recall number D-464-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 10,819 tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
Labeling: Label Mixup
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; CALCIUM CARBONATE +D3, Tablet, 600 mg/400 units may be potentially mis-labeled as DIGOXIN, Tablet, 125 mcg, NDC 00527132401, Pedigree: AD76675_4, EXP: 6/3/2014; or AMANTADINE HCL, Tablet, 100 mg, NDC 00832011100, Pedigree: AD54475_4, EXP: 5/20/2014.
Code information CALCIUM CARBONATE +D3, Tablet, 600 mg/400 units has the following codes: Pedigree: W002610, EXP: 6/4/2014; Pedigree: AD54576_1, EXP: 5/20/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[3487]
FDA event record
· Exact recall-number query on openFDA
drug · product 3 of 273
OMEGA-3 FATTY ACID, Capsule, 1000 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00904404360
D-465-2014
Recall number D-465-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 2,799 Capsules
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
Labeling: Label Mixup
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; OMEGA-3 FATTY ACID, Capsule, 1000 mg may be potentially mis-labeled as DOCUSATE CALCIUM, Capsule, 240 mg, NDC 00536375501, Pedigree: AD33897_16, EXP: 5/9/2014; OMEGA-3 FATTY ACID, Capsule, 1000 mg, NDC 00904404360, Pedigree: AD33897_19, EXP: 5/9/2014; PSEUDOEPHEDRINE HCL, Tablet, 60 mg, NDC 00904512559, Pedigree: W002856, EXP: 6/7/2014; DOCUSATE SODIUM, Capsule, 50 mg, N
Code information OMEGA-3 FATTY ACID, Capsule, 1000 mg has the following codes: Pedigree: AD33897_19, EXP: 5/9/2014; Pedigree: AD32328_5, EXP: 5/9/2014; Pedigree: W002852, EXP: 6/7/2014; Pedigree: AD62865_13, EXP: 5/23/2014; Pedigree: W002509, EXP: 6/3/2014; Pedigree: W003705, EXP: 6/25/2014; Pedigree: AD22845_7, EXP: 5/2/2014; Pedigree: AD39588_7, EXP:5/13/2014; Pedigree: AD73627_20, EXP: 5/30/2014; Pedigree: W003870, EXP: 6/27/2014; Pedigree: AD46300_14, EXP: 5/15/2014; Pedigree: AD60211_14, EXP: 5/22/2014; Pedigree: W003052, EXP: 6/12/2014; Pedigree: W003217, EXP: 6/14/2014; Pedigree: AD73623_4, EXP: 5/30/2014; Pedigree: W003462, EXP: 6/20/2014; Pedigree: W003195, EXP: 6/13/2014; Pedigree: W003473, EXP: 6/20/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[2712]
FDA event record
· Exact recall-number query on openFDA
drug · product 4 of 273
CYANOCOBALAMIN, Tablet, 1000 mcg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00904421713
D-466-2014
Recall number D-466-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 1,821 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; CYANOCOBALAMIN, Tablet, 1000 mcg may be potentially mislabeled as VITAMIN B COMPLEX W/C, Tablet, NDC 00904026013, Pedigree: AD21846_43, EXP: 5/1/2014; NIACIN TR, Capsule, 500 mg, NDC 00904063160, Pedigree: AD46257_22, EXP: 5/15/2014; chlorproMAZINE HCl, Tablet, 50 mg, NDC 00832030200, Pedigree: AD32973_4, EXP: 5/9/2014; PRENATAL MULTIVITAMIN/MULTIMINERAL, Tablet, NDC
Code information CYANOCOBALAMIN, Tablet, 1000 mcg has the following codes Pedigree: AD21846_46, EXP: 5/1/2014; Pedigree: AD46257_59, EXP: 5/15/2014; Pedigree: AD32582_3, EXP: 5/9/2014; Pedigree: AD60240_51, EXP: 5/22/2014; Pedigree: W002839, EXP: 6/7/2014; Pedigree: W003026, EXP: 6/12/2014; Pedigree: W003075, EXP: 6/12/2014; Pedigree: W003322, EXP: 6/19/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[2841]
FDA event record
· Exact recall-number query on openFDA
drug · product 5 of 273
NIACIN TR, Tablet, 500 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00904434260
D-467-2014
Recall number D-467-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 103 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; NIACIN TR, Tablet, 500 mg may be potentially mislabeled as LACTOBACILLUS GG, Capsule, NDC 49100036374, Pedigree: W002968, EXP: 6/11/2014.
Code information NIACIN TR, Tablet, 500 mg has the following code Pedigree: W002969, EXP: 6/11/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[2671]
FDA event record
· Exact recall-number query on openFDA
drug · product 6 of 273
COENZYME Q-10, Capsule, 30 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00904501546
D-468-2014
Recall number D-468-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 60 Capsules
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; COENZYME Q-10, Capsule, 30 mg may be potentially mislabeled as PANCRELIPASE DR, Capsule, 12000 /38000 /60000 USP units, NDC 00032121201, Pedigree: W002819, EXP: 6/7/2014.
Code information COENZYME Q-10, Capsule, 30 mg has the following code Pedigree: W002814, EXP: 6/7/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[2794]
FDA event record
· Exact recall-number query on openFDA
drug · product 7 of 273
PSEUDOEPHEDRINE HCL, Tablet, 30 mg, Rx in Oregon, Distributed by: AidaPak Service, LLC, NDC 00904505360
D-469-2014
Recall number D-469-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 100 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; PSEUDOEPHEDRINE HCL, Tablet, 30 mg may be potentially mislabeled as D-ALPHA TOCOPHERYL ACETATE, Capsule, 400 units, NDC 49348041010, Pedigree: AD52993_28, EXP: 5/20/2014.
Code information PSEUDOEPHEDRINE HCL, Tablet, 30 mg has the following code Pedigree: AD52993_37, EXP: 5/20/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[3887]
FDA event record
· Exact recall-number query on openFDA
drug · product 8 of 273
CALCIUM CITRATE, Tablet, 200 mg Elemental Calcium, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00904506260
D-470-2014
Recall number D-470-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 100 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; CALCIUM CITRATE, Tablet, 200 mg Elemental Calcium may be potentially mislabeled as TRIAMTERENE/HCTZ, Tablet, 37.5 mg/25 mg, NDC 00378135201, Pedigree: AD28333_4, EXP: 5/6/2014.
Code information CALCIUM CITRATE, Tablet, 200 mg Elemental Calcium has the following code Pedigree: AD28333_1, EXP: 5/8/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[3437]
FDA event record
· Exact recall-number query on openFDA
drug · product 9 of 273
CALCIUM CITRATE, Tablet, 950 mg (200 mg Elem Ca), Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00904506260
D-471-2014
Recall number D-471-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 900 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; CALCIUM CITRATE, Tablet, 950 mg (200 mg Elem Ca) may be potentially mislabeled as VALSARTAN, Tablet, 160 mg, NDC 00078035934, Pedigree: W002767, EXP: 6/6/2014; LACTOBACILLUS ACIDOPHILUS, Capsule, 500 MILLION CFU, NDC 43292050022, Pedigree: AD60240_20, EXP: 5/22/2014; PYRIDOXINE HCL, Tablet, 50 mg, NDC 51645090901, Pedigree: AD73521_25, EXP: 5/30/2014.
Code information CALCIUM CITRATE, Tablet, 950 mg (200 mg Elem Ca) has the following codes Pedigree: W002699, EXP: 6/5/2014; Pedigree: AD60240_27, EXP: 5/22/2014; Pedigree: AD73521_28, EXP: 5/30/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[2753]
FDA event record
· Exact recall-number query on openFDA
drug · product 10 of 273
CALCIUM CITRATE, Tablet, 950 mg (200 mg Elem Calcium), Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00904506260
D-472-2014
Recall number D-472-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 298 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; CALCIUM CITRATE, Tablet, 950 mg (200 mg Elem Calcium) may be potentially mislabeled as tiZANidine HCL, Tablet, 2 mg, NDC 57664050289, Pedigree: W003750, EXP: 6/26/2014.
Code information CALCIUM CITRATE, Tablet, 950 mg (200 mg Elem Calcium) has the following code Pedigree: W003720, EXP: 6/26/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[2744]
FDA event record
· Exact recall-number query on openFDA
drug · product 11 of 273
CALCIUM CITRATE, Tablet, 950 mg (200 MG ELEMENTAL Ca), Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00904506260
D-473-2014
Recall number D-473-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 200 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; CALCIUM CITRATE, Tablet, 950 mg (200 MG ELEMENTAL Ca) may be potentially mislabeled as TRIMETHOBENZAMIDE HCL, Capsule, 300 mg, NDC 53489037601, Pedigree: AD21858_10, EXP: 5/1/2014.
Code information CALCIUM CITRATE, Tablet, 950 mg (200 MG ELEMENTAL Ca) has the following code Pedigree: AD21846_24, EXP: 5/1/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[2839]
FDA event record
· Exact recall-number query on openFDA
drug · product 12 of 273
CALCIUM CITRATE, Tablet, 950 mg (200 mg Elemental Calcium), Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00904506260
D-474-2014
Recall number D-474-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 200 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; CALCIUM CITRATE, Tablet, 950 mg (200 mg Elemental Calcium) may be potentially mislabeled as LITHIUM CARBONATE ER, Tablet, 450 mg, NDC 00054002025, Pedigree: AD46265_10, EXP: 5/15/2014.
Code information CALCIUM CITRATE, Tablet, 950 mg (200 mg Elemental Calcium) has the following code Pedigree: AD46257_43, EXP: 5/15/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[4111]
FDA event record
· Exact recall-number query on openFDA
drug · product 13 of 273
PSEUDOEPHEDRINE HCL, Tablet, 60 mg, Rx in Oregon, Distributed by: AidaPak Service, LLC, NDC 00904512559
D-475-2014
Recall number D-475-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 100 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; PSEUDOEPHEDRINE HCL, Tablet, 60 mg may be potentially mislabeled as REPAGLINIDE, Tablet, 1 mg, NDC 00169008281, Pedigree: W002855, EXP: 6/7/2014.
Code information PSEUDOEPHEDRINE HCL, Tablet, 60 mg has the following code Pedigree: W002856, EXP: 6/7/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[4061]
FDA event record
· Exact recall-number query on openFDA
drug · product 14 of 273
ACETAMINOPHEN/ ASPIRIN/ CAFFEINE, Tablet, 250 mg/250 mg/65 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00904513559
D-476-2014
Recall number D-476-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 100 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; ACETAMINOPHEN/ ASPIRIN/ CAFFEINE, Tablet, 250 mg/250 mg/65 mg may be potentially mislabeled as NAPROXEN, Tablet, 500 mg, NDC 53746019001, Pedigree: AD68025_8, EXP: 5/28/2014.
Code information ACETAMINOPHEN/ ASPIRIN/ CAFFEINE, Tablet, 250 mg/250 mg/65 mg has the following code Pedigree: AD68022_4, EXP: 5/28/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[2799]
FDA event record
· Exact recall-number query on openFDA
drug · product 15 of 273
GUAIFENESIN, Tablet, 200 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00904515460
D-477-2014
Recall number D-477-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 100 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; GUAIFENESIN, Tablet, 200 mg may be potentially mislabeled as PANCRELIPASE DR, Capsule, 24000 /76000 /120000 USP units, NDC 00032122401, Pedigree: W002850, EXP: 6/7/2014.
Code information GUAIFENESIN, Tablet, 200 mg has the following code Pedigree: W002853, EXP: 6/7/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[4065]
FDA event record
· Exact recall-number query on openFDA
drug · product 16 of 273
PRENATAL MULTIVITAMIN/MULTIMINERAL, Tablet, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00904531360
D-478-2014
Recall number D-478-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 1,501 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; PRENATAL MULTIVITAMIN/MULTIMINERAL, Tablet may be potentially mislabeled as RILUZOLE, Tablet, 50 mg, NDC 00075770060, Pedigree: AD62992_11, EXP: 5/23/2014; ASPIRIN, Chew Tablet, 81 mg, NDC 00536329736, Pedigree: W003093, EXP: 6/13/2014; NIACIN TR, Capsule, 250 mg, NDC 00904062960, Pedigree: W003478, EXP: 6/20/2014; PRENATAL MULTIVITAMIN/MULTIMINERAL, Tablet, NDC 009045
Code information PRENATAL MULTIVITAMIN/MULTIMINERAL, Tablet has the following codes Pedigree: AD62986_22, EXP: 5/23/2014; Pedigree: W003098, EXP: 6/13/2014; Pedigree: W003479, EXP: 6/20/2014; Pedigree: W003480, EXP: 6/20/2014; Pedigree: AD52993_13, EXP: 5/20/2014; Pedigree: AD60428_7, EXP: 5/22/2014; Pedigree: AD73652_16, EXP: 5/30/2014; Pedigree: W003706, 6/25/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[4108]
FDA event record
· Exact recall-number query on openFDA
drug · product 17 of 273
ZINC SULFATE, Capsule, 220 mg (50 mg Elem Zn), Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00904533260
D-479-2014
Recall number D-479-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 99 Capsules
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; ZINC SULFATE, Capsule, 220 mg (50 mg Elem Zn) may be potentially mislabeled as PHOSPHORUS, Tablet, 250 mg, NDC 64980010401, Pedigree: AD56916_1, EXP: 5/21/2014.
Code information ZINC SULFATE, Capsule, 220 mg (50 mg Elem Zn) has the following code Pedigree: AD57624_1, EXP: 5/9/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[1857]
FDA event record
· Exact recall-number query on openFDA
drug · product 18 of 273
ZINC SULFATE, Capsule, 50 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00904533260
D-480-2014
Recall number D-480-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 100 Capsules
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; ZINC SULFATE, Capsule, 50 mg may be potentially mislabeled as SERTRALINE HCL, Tablet, 50 mg, NDC 16714061204, Pedigree: AD30993_14, EXP: 5/9/2014.
Code information ZINC SULFATE, Capsule, 50 mg has the following code Pedigree: AD30994_8, EXP: 5/9/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[2852]
FDA event record
· Exact recall-number query on openFDA
drug · product 19 of 273
GLUCOSAMINE/CHONDROITIN DS, Capsule, 500 mg/400 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00904548152
D-481-2014
Recall number D-481-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 180 Capsules
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; GLUCOSAMINE/CHONDROITIN DS, Capsule, 500 mg/400 mg may be potentially mislabeled as GLYCOPYRROLATE, Tablet, 2 mg, NDC 00603318121, Pedigree: AD22865_4, EXP: 5/2/2014; PREGABALIN, Capsule, 25 mg, NDC 00071101268, Pedigree: W003121, EXP: 6/13/2014; MULTIVITAMIN/MULTIMINERAL, Chew Tablet, NDC 00536344308, Pedigree: AD73521_10, EXP: 5/30/2014.
Code information GLUCOSAMINE/CHONDROITIN DS, Capsule, 500 mg/400 mg has the following codes Pedigree: AD21846_14, EXP: 5/1/2014; Pedigree: W003316, EXP: 6/18/2014; Pedigree: AD73521_16, EXP: 5/30/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[1256]
FDA event record
· Exact recall-number query on openFDA
drug · product 20 of 273
MULTIVITAMIN/MULTIMINERAL, Tablet, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00904549213
D-482-2014
Recall number D-482-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 520 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; MULTIVITAMIN/MULTIMINERAL, Tablet may be potentially mislabeled as LISINOPRIL, Tablet, 2.5 mg, NDC 64679092701, Pedigree: AD25264_4, EXP: 5/3/2014.
Code information MULTIVITAMIN/MULTIMINERAL, Tablet has the following code Pedigree: AD23082_13, EXP: 11/1/2013.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[4087]
FDA event record
· Exact recall-number query on openFDA
drug · product 21 of 273
diphenhydrAMINE HCl, Tablet, 25 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00904555159
D-483-2014
Recall number D-483-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 901 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; diphenhydrAMINE HCl, Tablet, 25 mg may be potentially mislabeled as ATORVASTATIN CALCIUM, Tablet, 40 mg, NDC 00378212177, Pedigree: AD33897_10, EXP: 5/9/2014; ATORVASTATIN CALCIUM, Tablet, 10 mg, NDC 00378201577, Pedigree: W002774, EXP: 6/6/2014; PRENATAL MULTIVITAMIN/ MULTIMINERAL, Tablet, NDC 51991056601, Pedigree: W003511, EXP: 6/21/2014; VENLAFAXINE, Tablet, 25 mg
Code information diphenhydrAMINE HCl, Tablet, 25 mg has the following codes Pedigree: AD33897_13, EXP: 5/9/2014; Pedigree: W002775, EXP: 6/6/2014; Pedigree: W003513, EXP: 6/21/2014; Pedigree: AD67992_4, EXP: 5/28/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[2814]
FDA event record
· Exact recall-number query on openFDA
drug · product 22 of 273
GLUCOSAMINE/CHONDROITIN DS, Tablet, 500 mg/400 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00904559293
D-484-2014
Recall number D-484-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 180 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; GLUCOSAMINE/CHONDROITIN DS, Tablet, 500 mg/400 mg may be potentially mislabeled as DOCUSATE SODIUM, Capsule, 250 mg, NDC 00536375701, Pedigree: AD60211_11, EXP: 5/22/2014.
Code information GLUCOSAMINE/CHONDROITIN DS, Tablet, 500 mg/400 mg has the following code Pedigree: AD60211_17, EXP: 5/22/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[1806]
FDA event record
· Exact recall-number query on openFDA
drug · product 23 of 273
CHOLECALCIFEROL, Tablet, 400 units, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00904582360
D-485-2014
Recall number D-485-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 1,199 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; CHOLECALCIFEROL, Tablet, 400 units may be potentially mislabeled as CYANOCOBALAMIN, Tablet, 500 mcg, NDC 00536355101, Pedigree: AD37056_10, EXP: 5/10/2014; ROSUVASTATIN CALCIUM, Tablet, 5 mg, NDC 00310075590, Pedigree: W002567, EXP: 6/3/2014; PYRIDOXINE HCL, Tablet, 100 mg, NDC 00536440901, Pedigree: AD76686_4, EXP: 5/31/2014; CYANOCOBALAMIN, Tablet, 500 mcg, NDC 0053
Code information CHOLECALCIFEROL, Tablet, 400 units has the following codes Pedigree: AD37056_13, EXP: 5/10/2014; Pedigree: W002574, EXP: 6/3/2014; Pedigree: AD76686_7, EXP: 5/31/2014; Pedigree: AD60578_27, EXP: 5/29/2014; Pedigree: W003540, EXP: 6/21/2014; Pedigree: AD52993_25, EXP: 5/20/2014; Pedigree: W002715, EXP: 6/5/2014; Pedigree: AD30197_31, EXP: 5/9/2014; Pedigree: AD73592_8, EXP: 5/31/2014; Pedigree: W002642, EXP: 6/4/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[1836]
FDA event record
· Exact recall-number query on openFDA
drug · product 24 of 273
CHOLECALCIFEROL, Tablet, 1000 units, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00904582460
D-486-2014
Recall number D-486-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 2,399 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; CHOLECALCIFEROL, Tablet, 1000 units may be potentially mislabeled as ASPIRIN, Chew Tablet, 81 mg, NDC 00536329736, Pedigree: W003459, EXP: 6/20/2014; MULTIVITAMIN/MULTIMINERAL, Tablet, NDC 37205018581, Pedigree: AD32328_8, EXP: 5/9/2014; CHOLECALCIFEROL, Tablet, 400 units, NDC 00904582360, Pedigree: W002715, EXP: 6/5/2014; GLYCOPYRROLATE, Tablet, 2 mg, NDC 49884006601
Code information CHOLECALCIFEROL, Tablet, 1000 units has the following codes Pedigree: W003464, EXP: 6/20/2014; Pedigree: AD33897_37, EXP: 5/9/2014; Pedigree: W002779, EXP: 6/6/2014; Pedigree: W003626, EXP: 6/25/2014; Pedigree: W003827, EXP: 6/27/2014; Pedigree: AD33897_34, EXP: 5/9/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[3453]
FDA event record
· Exact recall-number query on openFDA
drug · product 25 of 273
CHOLECALCIFEROL, Capsule, 5000 units, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 0904598660
D-487-2014
Recall number D-487-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 300 Capsules
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; CHOLECALCIFEROL, Capsule, 5000 units may be potentially mislabeled as SEVELAMER CARBONATE, Tablet, 800 mg, NDC 58468013001, Pedigree: AD70629_16, EXP: 5/29/2014; CHOLECALCIFEROL, Tablet, 400 units, NDC 00904582360, Pedigree: W003540, EXP: 6/21/2014; THIAMINE HCL, Tablet, 100 mg, NDC 00904054460, Pedigree: AD52993_16, EXP: 5/20/2014.
Code information CHOLECALCIFEROL, Capsule, 5000 units has the following codes Pedigree: AD70629_19, EXP: 5/29/2014; Pedigree: W003541, EXP: 6/21/2014; Pedigree: AD52993_22, EXP: 5/20/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[3555]
FDA event record
· Exact recall-number query on openFDA
drug · product 26 of 273
CHOLECALCIFEROL, Tablet, 2000 units, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00904615760
D-488-2014
Recall number D-488-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 2,998 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; CHOLECALCIFEROL, Tablet, 2000 units may be potentially mislabeled as PYRIDOXINE HCL, Tablet, 50 mg, NDC 00904052060, Pedigree: AD46312_34, EXP: 5/16/2014; PRENATAL MULTIVITAMIN/MULTIMINERAL, Tablet, NDC 13811051410, Pedigree: AD65314_1, EXP: 5/24/2014; RANOLAZINE ER, Tablet, 500 mg, NDC 61958100301, Pedigree: W003538, EXP: 6/21/2014; LEVOTHYROXINE SODIUM, Tablet, 175
Code information CHOLECALCIFEROL, Tablet, 2000 units has the following codes Pedigree: AD46312_37, EXP: 5/16/2014; Pedigree: AD65311_1, EXP: 5/24/2014; Pedigree: W003539, EXP: 6/21/2014; Pedigree: W003744, EXP: 6/26/2014; Pedigree: AD54586_10, EXP: 5/21/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[3475]
FDA event record
· Exact recall-number query on openFDA
drug · product 27 of 273
FERROUS SULFATE, Tablet, 325 mg (65 mg Elem Fe), Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00904759160
D-489-2014
Recall number D-489-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 402 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; FERROUS SULFATE, Tablet, 325 mg (65 mg Elem Fe) may be potentially mislabeled as COENZYME Q-10, Capsule, 100 mg, NDC 37205055065, Pedigree: W002711, EXP: 6/6/2014; VENLAFAXINE HCL, Tablet, 25 mg, NDC 00093019901, Pedigree: W002825, EXP: 12/31/2013; DOCUSATE SODIUM, Capsule, 250 mg, NDC 00536375710, Pedigree: AD60236_1, EXP: 5/22/2014.
Code information FERROUS SULFATE, Tablet, 325 mg (65 mg Elem Fe) has the following codes Pedigree: W002717, EXP: 6/6/2014; Pedigree: W002826, EXP: 6/7/2014; Pedigree: AD60268_1, EXP: 5/22/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[4073]
FDA event record
· Exact recall-number query on openFDA
drug · product 28 of 273
FERROUS SULFATE, Tablet, 325 mg (65 mg Elemental Iron), Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00904759160
D-490-2014
Recall number D-490-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 100 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; FERROUS SULFATE, Tablet, 325 mg (65 mg Elemental Iron) may be potentially mislabeled as RAMIPRIL, Capsule, 2.5 mg, NDC 68180058901, Pedigree: AD54549_16, EXP: 5/20/2014.
Code information FERROUS SULFATE, Tablet, 325 mg (65 mg Elemental Iron) has the following code Pedigree: AD54553_1, EXP: 5/20/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[3631]
FDA event record
· Exact recall-number query on openFDA
drug · product 29 of 273
DOCUSATE SODIUM, Capsule, 250 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00904789159
D-491-2014
Recall number D-491-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 4,318 Capsules
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; DOCUSATE SODIUM, Capsule, 250 mg may be potentially mislabeled as ATROPINE SULFATE/DIPHENOXYLATE HCL, Tablet, 0.025 mg/2.5 mg, NDC 00378041501, Pedigree: AD65475_13, EXP: 5/28/2014; VALSARTAN, Tablet, 80 mg, NDC 00078035834, Pedigree: AD68025_1, EXP: 5/28/2014; PANTOPRAZOLE SODIUM DR, Tablet, 40 mg, NDC 64679043402, Pedigree: AD37063_10, EXP: 5/13/2014; DOCUSATE SODIUM
Code information DOCUSATE SODIUM, Capsule, 250 mg has the following codes Pedigree: AD68028_1, EXP: 5/28/2014; Pedigree: AD68022_1, EXP: 5/28/2014; Pedigree: AD37072_1, EXP: 5/13/2014; Pedigree: AD37072_4, EXP: 5/13/2014; Pedigree: AD56924_1, EXP: 5/21/2014; Pedigree: W003671, EXP: 6/25/2014; Pedigree: W002920, EXP: 6/10/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[3924]
FDA event record
· Exact recall-number query on openFDA
drug · product 30 of 273
MAGNESIUM CHLORIDE DR, Tablet, 64 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00904791152
D-492-2014
Recall number D-492-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 180 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; MAGNESIUM CHLORIDE DR, Tablet, 64 mg may be potentially mislabeled as SELEGILINE HCL, Capsule, 5 mg, NDC 67253070006, Pedigree: AD54549_19, EXP: 5/20/2014; PHOSPHORUS, Tablet, 250 mg, NDC 64980010401, Pedigree: AD70639_10, EXP: 5/29/2014.
Code information MAGNESIUM CHLORIDE DR, Tablet, 64 mg has the following codes Pedigree: AD54510_1, EXP: 2/28/2014; Pedigree: AD70615_1, EXP: 2/28/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[3872]
FDA event record
· Exact recall-number query on openFDA
drug · product 31 of 273
BISACODYL EC, Tablet, 5 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00904792760
D-493-2014
Recall number D-493-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 100 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; BISACODYL EC, Tablet, 5 mg may be potentially mislabeled as CHOLECALCIFEROL, Tablet, 400 units, NDC 00904582360, Pedigree: AD37056_13, EXP: 5/10/2014.
Code information BISACODYL EC, Tablet, 5 mg has the following code Pedigree: AD34931_1, EXP: 5/9/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[4082]
FDA event record
· Exact recall-number query on openFDA
drug · product 32 of 273
MELATONIN, Tablet, 1 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 04746900466
D-494-2014
Recall number D-494-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 359 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; MELATONIN, Tablet, 1 mg may be potentially mislabeled as QUETIAPINE FUMARATE, Tablet, 12.5 MG (1/2 of 25 MG), NDC 47335090288, Pedigree: AD21790_79, EXP: 5/1/2014; DOCUSATE SODIUM, Capsule, 250 mg, NDC 00536375710, Pedigree: AD73521_13, EXP: 5/30/2014.
Code information MELATONIN, Tablet, 1 mg has the following codes Pedigree: AD21846_17, EXP: 5/1/2014; Pedigree: AD73521_19, EXP: 5/30/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[3627]
FDA event record
· Exact recall-number query on openFDA
drug · product 33 of 273
NAPROXEN, Tablet, 500 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 05374601901
D-495-2014
Recall number D-495-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 200 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; NAPROXEN, Tablet, 500 mg may be potentially mislabeled as THIOTHIXENE, Capsule, 1 mg, NDC 00378100101, Pedigree: AD54549_22, EXP: 5/20/2014; HYDROCHLOROTHIAZIDE, Tablet, 12.5 mg, NDC 00228282011, Pedigree: AD67989_13, EXP: 5/28/2014.
Code information NAPROXEN, Tablet, 500 mg has the following codes Pedigree: AD54516_1, EXP: 5/20/2014; Pedigree: AD68025_8, EXP: 5/28/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[3600]
FDA event record
· Exact recall-number query on openFDA
drug · product 34 of 273
OMEGA-3 FATTY ACID, Capsule, 1000 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 05445800022
D-496-2014
Recall number D-496-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 90 Capsules
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; OMEGA-3 FATTY ACID, Capsule, 1000 mg may be potentially mislabeled as NORTRIPTYLINE HCL, Capsule, 50 mg, NDC 00093081201, Pedigree: AD21790_70, EXP: 5/1/2014.
Code information OMEGA-3 FATTY ACID, Capsule, 1000 mg has the following code Pedigree: AD21858_4, EXP: 5/1/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[3647]
FDA event record
· Exact recall-number query on openFDA
drug · product 35 of 273
MELATONIN, Tablet, 3 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 08770140813
D-497-2014
Recall number D-497-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 3,710 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; MELATONIN, Tablet, 3 mg may be potentially mislabeled as VITAMIN B COMPLEX, Capsule, NDC 00536478701, Pedigree: AD32757_4, EXP: 5/13/2014; MULTIVITAMIN/ MULTIMINERAL/ LUTEIN, Capsule, NDC 24208063210, Pedigree: W003025, EXP: 6/12/2014; LACTASE ENZYME, Tablet, 3000 units, NDC 24385014976, Pedigree: W003721, EXP: 6/26/2014; GLUCOSAMINE/CHONDROITIN DS, Capsule, 500 mg/400
Code information MELATONIN, Tablet, 3 mg has the following codes Pedigree: AD46257_56, EXP: 5/15/2014; Pedigree: W003022, EXP: 6/12/2014; Pedigree: W003723, EXP: 6/26/2014; Pedigree: AD21846_34, EXP: 5/1/2014; Pedigree: AD30028_28, EXP: 5/7/2014; Pedigree: AD60240_39, EXP: 5/22/2014; Pedigree: AD73521_31, EXP: 5/30/2014; Pedigree: W002701, EXP: 6/5/2014; Pedigree: W003320, EXP: 6/19/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[1268]
FDA event record
· Exact recall-number query on openFDA
drug · product 36 of 273
GALANTAMINE HBr ER, Capsule, 8 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 10147089103
D-498-2014
Recall number D-498-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 30 Capsules
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; GALANTAMINE HBr ER, Capsule, 8 mg may be potentially mislabeled as FAMOTIDINE, Tablet, 20 mg, NDC 16714036104, Pedigree: W003508, EXP: 6/21/2014.
Code information GALANTAMINE HBr ER, Capsule, 8 mg has the following code Pedigree: W003509, EXP: 6/21/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[1864]
FDA event record
· Exact recall-number query on openFDA
drug · product 37 of 273
ITRACONAZOLE, Capsule, 100 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 10147170003
D-499-2014
Recall number D-499-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 30 Capsules
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; ITRACONAZOLE, Capsule, 100 mg may be potentially mislabeled as FAMCICLOVIR, Tablet, 500 mg, NDC 00093811956, Pedigree: AD54549_4, EXP: 5/20/2014.
Code information ITRACONAZOLE, Capsule, 100 mg has the following code Pedigree: AD54549_10, EXP: 5/20/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[3472]
FDA event record
· Exact recall-number query on openFDA
drug · product 38 of 273
NIACIN TR, Tablet, 250 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 10939043533
D-500-2014
Recall number D-500-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 101 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; NIACIN TR, Tablet, 250 mg may be potentially mislabeled as SOLIFENACIN SUCCINATE, Tablet, 5 mg, NDC 51248015001, Pedigree: W003755, EXP: 6/26/2014.
Code information NIACIN TR, Tablet, 250 mg has the following code Pedigree: W003756, EXP: 5/31/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[2811]
FDA event record
· Exact recall-number query on openFDA
drug · product 39 of 273
OMEPRAZOLE/SODIUM BICARBONATE, Capsule, 20 mg/1,100 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 11523726503
D-501-2014
Recall number D-501-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 210 Capsules
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; OMEPRAZOLE/SODIUM BICARBONATE, Capsule, 20 mg/1,100 mg may be potentially mislabeled as CYANOCOBALAMIN, Tablet, 1000 mcg, NDC 00536355601, Pedigree: W003788, EXP: 6/27/2014; OMEGA-3 FATTY ACID, Capsule, 1000 mg, NDC 00904404360, Pedigree: W003870, EXP: 6/27/2014.
Code information OMEPRAZOLE/SODIUM BICARBONATE, Capsule, 20 mg/1,100 mg has the following codes Pedigree: W003789, EXP: 6/27/2014; Pedigree: W003873, EXP: 6/27/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[3573]
FDA event record
· Exact recall-number query on openFDA
drug · product 40 of 273
OMEPRAZOLE/SODIUM BICARBONATE, Capsule, 20 mg/1,110 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 11523726503
D-502-2014
Recall number D-502-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 294 Capsules
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; OMEPRAZOLE/SODIUM BICARBONATE, Capsule, 20 mg/1,110 mg may be potentially mislabeled as ACETAMINOPHEN, CHEW Tablet, 80 mg, NDC 00536323307, Pedigree: AD49399_1, EXP: 5/16/2014; LACTOBACILLUS GG, Capsule, NDC 49100036374, Pedigree: AD46300_11, EXP: 5/15/2014; MYCOPHENOLATE MOFETIL, Capsule, 250 mg, NDC 00781206701, Pedigree: AD65457_7, EXP: 5/24/2014.
Code information OMEPRAZOLE/SODIUM BICARBONATE, Capsule, 20 mg/1,110 mg has the following codes Pedigree: AD49399_4, EXP: 5/16/2014; Pedigree: AD46300_17, EXP: 5/15/2014; Pedigree: AD65457_22, EXP: 5/24/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[1835]
FDA event record
· Exact recall-number query on openFDA
drug · product 41 of 273
OMEPRAZOLE/SODIUM BICARBONATE, Capsule, 20 mg/110 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 11523726503
D-503-2014
Recall number D-503-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 84 Capsules
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; OMEPRAZOLE/SODIUM BICARBONATE, Capsule, 20 mg/110 mg may be potentially mislabeled as BENZOCAINE/MENTHOL, LOZENGE, 15 mg/2.6 mg, NDC 63824073116, Pedigree: AD42592_4, EXP: 5/14/2014.
Code information OMEPRAZOLE/SODIUM BICARBONATE, Capsule, 20 mg/110 mg has the following code Pedigree: AD42584_15, EXP: 5/14/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[1802]
FDA event record
· Exact recall-number query on openFDA
drug · product 42 of 273
OMEPRAZOLE/SODIUM BICARBONATE, Capsule, 20 mg/1110 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 11523726503
D-504-2014
Recall number D-504-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 210 Capsules
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; OMEPRAZOLE/SODIUM BICARBONATE, Capsule, 20 mg/1110 mg may be potentially mislabeled as LACTOBACILLUS GG, Capsule, NDC 49100036374, Pedigree: AD70655_8, EXP: 5/29/2014; PYRIDOXINE HCL, Tablet, 100 mg, NDC 00536440901, Pedigree: AD73627_32, EXP: 5/30/2014.
Code information OMEPRAZOLE/SODIUM BICARBONATE, Capsule, 20 mg/1110 mg has the following codes Pedigree: AD70655_20, EXP: 5/29/2014; Pedigree: AD73627_35, EXP: 5/30/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[3928]
FDA event record
· Exact recall-number query on openFDA
drug · product 43 of 273
OMEGA-3 FATTY ACID, Capsule, 1000 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 11845014882
D-505-2014
Recall number D-505-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 116 Capsules
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; OMEGA-3 FATTY ACID, Capsule, 1000 mg may be potentially mislabeled as tiZANidine HCL, Tablet, 2 mg, NDC 57664050289, Pedigree: AD70700_10, EXP: 5/29/2014.
Code information OMEGA-3 FATTY ACID, Capsule, 1000 mg has the following code Pedigree: AD70700_7, EXP: 5/29/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[3613]
FDA event record
· Exact recall-number query on openFDA
drug · product 44 of 273
CHLOROPHYLLIN COPPER COMPLEX, Tablet, 100 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 11868000901
D-506-2014
Recall number D-506-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 135 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; CHLOROPHYLLIN COPPER COMPLEX, Tablet, 100 mg may be potentially mislabeled as traZODone HCl, Tablet, 50 mg, NDC 50111043301, Pedigree: AD37088_4, EXP: 5/9/2014.
Code information CHLOROPHYLLIN COPPER COMPLEX, Tablet, 100 mg has the following code Pedigree: AD34928_1, EXP: 5/9/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[1844]
FDA event record
· Exact recall-number query on openFDA
drug · product 45 of 273
PARoxetine HCl, Tablet, 10 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 13107015430
D-507-2014
Recall number D-507-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 30 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; PARoxetine HCl, Tablet, 10 mg may be potentially mislabeled as PANTOPRAZOLE SODIUM DR, Tablet, 20 mg, NDC 62175018046, Pedigree: AD52778_64, EXP: 5/20/2014.
Code information PARoxetine HCl, Tablet, 10 mg has the following code Pedigree: AD52778_67, EXP: 5/20/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[1263]
FDA event record
· Exact recall-number query on openFDA
drug · product 46 of 273
lamoTRIgine, Tablet, 50 mg (1/2 of 100 mg), Rx only, Distributed by: AidaPak Service, LLC, NDC 13668004701
D-508-2014
Recall number D-508-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 600 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; lamotrigine, Tablet, 50 mg (1/2 of 100 mg) may be potentially mislabeled as OXYBUTYNIN CHLORIDE, Tablet, 2.5 mg (1/2 of 5 mg), NDC 00603497521, Pedigree: AD73525_64, EXP: 5/30/2014; FEXOFENADINE HCL, Tablet, 60 mg, NDC 45802042578, Pedigree: AD46257_50, EXP: 5/15/2014.
Code information lamoTRIgine, Tablet, 50 mg (1/2 of 100 mg) has the following codes Pedigree: ADWA00002116, EXP: 5/31/2014; Pedigree: AD46265_31, EXP: 5/15/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[1591]
FDA event record
· Exact recall-number query on openFDA
drug · product 47 of 273
PRAMIPEXOLE DI-HCL, Tablet, 0.125 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 13668009190
D-509-2014
Recall number D-509-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 359 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; PRAMIPEXOLE DI-HCL, Tablet, 0.125 mg may be potentially mislabeled as MULTIVITAMIN/MULTIMINERAL, Tablet, NDC 00904549213, Pedigree: AD23082_13, EXP: 11/1/2013; PERPHENAZINE, Tablet, 16 mg, NDC 00781104901, Pedigree: W003682, EXP: 6/25/2014.
Code information PRAMIPEXOLE DI-HCL, Tablet, 0.125 mg has the following codes Pedigree: AD25264_10, EXP: 5/3/2014; Pedigree: W003683, EXP: 6/25/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[3582]
FDA event record
· Exact recall-number query on openFDA
drug · product 48 of 273
PANTOPRAZOLE SODIUM DR, Tablet, 20 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 13668009690
D-510-2014
Recall number D-510-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 90 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabel
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; PANTOPRAZOLE SODIUM DR, Tablet, 20 mg may be potentially mislabel as NORTRIPTYLINE HCL, Capsule, 75 mg, NDC 00093081301, Pedigree: W003694, EXP: 6/26/2014.
Code information PANTOPRAZOLE SODIUM DR, Tablet, 20 mg has the following code Pedigree: W003695, EXP: 6/26/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[1568]
FDA event record
· Exact recall-number query on openFDA
drug · product 49 of 273
LOSARTAN POTASSIUM, Tablet, 25 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 13668011390
D-511-2014
Recall number D-511-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 180 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; LOSARTAN POTASSIUM, Tablet, 25 mg may be potentially mislabeled as DISOPYRAMIDE PHOSPHATE, Capsule, 150 mg, NDC 00093312901, Pedigree: AD65323_4, EXP: 5/29/2014.
Code information LOSARTAN POTASSIUM, Tablet, 25 mg has the following code Pedigree: AD65323_10, EXP: 5/29/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[1642]
FDA event record
· Exact recall-number query on openFDA
drug · product 50 of 273
PRENATAL MULTIVITAMIN/MULTIMINERAL, Tablet, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 13811051410
D-512-2014
Recall number D-512-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 2,400 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; PRENATAL MULTIVITAMIN/MULTIMINERAL, Tablet may be potentially mislabeled as CYANOCOBALAMIN, Tablet, 100 mcg, NDC 00536354201, Pedigree: AD62840_1, EXP: 5/24/2014.
Code information PRENATAL MULTIVITAMIN/MULTIMINERAL, Tablet has the following code Pedigree: AD65314_1, EXP: 5/24/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[3920]
FDA event record
· Exact recall-number query on openFDA
drug · product 51 of 273
prednisoLONE, Tablet, 5 mg, Rx only, Distributed by: AidaPak Service, LLC,NDC 16477050501
D-513-2014
Recall number D-513-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 100 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; prednisoLONE, Tablet, 5 mg may be potentially mislabeled as ASPIRIN/ER DIPYRIDAMOLE, Capsule, 25 mg/200 mg, NDC 00597000160, Pedigree: W003644, EXP: 8/24/2013.
Code information prednisoLONE, Tablet, 5 mg has the following code Pedigree: W003627, EXP: 6/25/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[2715]
FDA event record
· Exact recall-number query on openFDA
drug · product 52 of 273
PROPRANOLOL HCL, Tablet, 10 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 16714002104
D-514-2014
Recall number D-514-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 100 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; PROPRANOLOL HCL, Tablet, 10 mg may be potentially mislabeled as PIOGLITAZONE HCL, Tablet, 15 mg, NDC 00093204856, Pedigree: AD52778_70, EXP: 5/21/2014.
Code information PROPRANOLOL HCL, Tablet, 10 mg has the following code Pedigree: AD52778_73, EXP: 5/21/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[2859]
FDA event record
· Exact recall-number query on openFDA
drug · product 53 of 273
ALLOPURINOL Tablet, 300 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 16714004204
D-515-2014
Recall number D-515-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 100 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; ALLOPURINOL Tablet, 300 mg may be potentially mislabeled as CHOLECALCIFEROL, Tablet, 400 units, NDC 00904582360, Pedigree: AD52993_25, EXP: 5/20/2014.
Code information ALLOPURINOL Tablet, 300 mg has the following code Pedigree: AD52778_1, EXP: 5/20/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[3462]
FDA event record
· Exact recall-number query on openFDA
drug · product 54 of 273
VENLAFAXINE Tablet, 25 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 16714031101
D-516-2014
Recall number D-516-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 100 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; VENLAFAXINE Tablet, 25 mg may be potentially mislabeled as OMEPRAZOLE/SODIUM BICARBONATE, Capsule, 20 mg/1,110 mg, NDC 11523726503, Pedigree: AD65457_22, EXP: 5/24/2014.
Code information VENLAFAXINE Tablet, 25 mg has the following code Pedigree: AD67989_4, EXP: 11/30/2013.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[3935]
FDA event record
· Exact recall-number query on openFDA
drug · product 55 of 273
FLUoxetine HCl Capsule, 10 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 16714035103
D-517-2014
Recall number D-517-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 100 Capsules
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; FLUoxetine HCl, Capsule, 10 mg may be potentially mislabeled as PANCRELIPASE DR, Capsule, 24000 /76000 /120000 USP units, NDC 00032122401, Pedigree: AD70585_10, EXP: 5/29/2014.
Code information FLUoxetine HCl, Capsule, 10 mg has the following code Pedigree: AD70585_13, EXP: 5/29/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[2727]
FDA event record
· Exact recall-number query on openFDA
drug · product 56 of 273
FAMOTIDINE Tablet, 20 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 16714036104
D-518-2014
Recall number D-518-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 700 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; FAMOTIDINE Tablet, 20 mg may be potentially mislabeled as CARVEDILOL PHOSPHATE ER, Capsule, 20 mg, NDC 00007337113, Pedigree: W003225, EXP: 6/17/2014; DULoxetine HCl DR, Capsule, 20 mg, NDC 00002323560, Pedigree: W003506, EXP: 6/21/2014; FAMOTIDINE, Tablet, 20 mg, NDC 16714036104, Pedigree: W003507, EXP: 6/21/2014; MYCOPHENOLATE MOFETIL, Capsule, 250 mg, NDC 0037822500
Code information FAMOTIDINE Tablet, 20 mg has the following codes Pedigree: W003226, EXP: 6/17/2014; Pedigree: W003507, EXP: 6/21/2014; Pedigree: W003508, EXP: 6/21/2014; Pedigree: W003764, EXP: 6/26/2014; Pedigree: W003406, EXP: 6/19/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[3653]
FDA event record
· Exact recall-number query on openFDA
drug · product 57 of 273
FINASTERIDE Tablet, 5 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 16714052201
D-519-2014
Recall number D-519-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 120 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; FINASTERIDE, Tablet, 5 mg may be potentially mislabeled as DIGOXIN, Tablet, 0.125 mg, NDC 00115981101, Pedigree: AD62829_8, EXP: 5/23/2014; PHYTONADIONE, Tablet, 5 mg, NDC 25010040515, Pedigree: W003061, EXP: 5/31/2014.
Code information FINASTERIDE Tablet, 5 mg has the following codes Pedigree: AD62846_1, EXP: 2/28/2014; Pedigree: W003031, EXP: 2/28/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[2848]
FDA event record
· Exact recall-number query on openFDA
drug · product 58 of 273
LOSARTAN POTASSIUM Tablet, 25 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 16714058102
D-520-2014
Recall number D-520-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 448 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; LOSARTAN POTASSIUM, Tablet, 25 mg may be potentially mislabeled as DOCUSATE SODIUM, Capsule, 250 mg, NDC 00904789159, Pedigree: AD68028_1, EXP: 5/28/2014; METOPROLOL TARTRATE, Tablet, 50 mg, NDC 00093073301, Pedigree: W003844, EXP: 6/27/2014; LACTOBACILLUS ACIDOPHILUS, Tablet, 35 Million, NDC 00536718101, Pedigree: W003865, EXP: 6/27/2014; OXYBUTYNIN CHLORIDE, Tablet,
Code information LOSARTAN POTASSIUM Tablet, 25 mg has the following codes Pedigree: AD67989_7, EXP: 5/28/2014; Pedigree: W003845, EXP: 6/27/2014; Pedigree: W003899, EXP: 6/27/2014; Pedigree: AD22616_7, EXP: 5/2/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[2762]
FDA event record
· Exact recall-number query on openFDA
drug · product 59 of 273
PRAMIPEXOLE DI-HCL Tablet, 0.25 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 16714058501
D-521-2014
Recall number D-521-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 90 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; PRAMIPEXOLE DI-HCL, Tablet, 0.25 mg may be potentially mislabeled as TACROLIMUS, Capsule, 1 mg, NDC 00781210301, Pedigree: W003704, EXP: 6/26/2014.
Code information PRAMIPEXOLE DI-HCL Tablet, 0.25 mg has the following code Pedigree: W003761, EXP: 6/26/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[3451]
FDA event record
· Exact recall-number query on openFDA
drug · product 60 of 273
PRAMIPEXOLE DI-HCL Tablet, 1 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 16714058701
D-522-2014
Recall number D-522-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 90 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabel
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; PRAMIPEXOLE DI-HCL, Tablet, 1 mg may be potentially mislabel as MISOPROSTOL, Tablet, 200 mcg, NDC 59762500801, Pedigree: W003117, EXP: 6/13/2014.
Code information PRAMIPEXOLE DI-HCL Tablet, 1 mg has the following code Pedigree: W003150, EXP: 6/13/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[3681]
FDA event record
· Exact recall-number query on openFDA
drug · product 61 of 273
SERTRALINE HCL Tablet, 50 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 16714061204
D-523-2014
Recall number D-523-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 500 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; SERTRALINE HCL Tablet, 50 mg may be potentially mislabeled as NORTRIPTYLINE HCL, Capsule, 10 mg, NDC 00093081001, Pedigree: AD70585_4, EXP: 5/29/2014; guaiFENesin ER, Tablet, 600 mg, NDC 63824000834, Pedigree: W003574, EXP: 6/24/2014; OMEPRAZOLE/SODIUM BICARBONATE, Capsule, 20 mg/1,110 mg, NDC 11523726503, Pedigree: AD46300_17, EXP: 5/15/2014; CHOLECALCIFEROL, Tablet,
Code information SERTRALINE HCL Tablet, 50 mg has the following codes Pedigree: AD70585_7, EXP: 5/29/2014; Pedigree: W003575, EXP: 6/24/2014; Pedigree: AD46426_1, EXP: 5/15/2014; Pedigree: AD30993_14, EXP: 5/9/2014; Pedigree: W003033, EXP: 6/12/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[1632]
FDA event record
· Exact recall-number query on openFDA
drug · product 62 of 273
SIMVASTATIN Tablet, 20 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 16714068303
D-524-2014
Recall number D-524-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 1,000 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; SIMVASTATIN Tablet, 20 mg may be potentially mislabeled as VITAMIN B COMPLEX WITH C/FOLIC ACID, Tablet, NDC 60258016001, Pedigree: W003591, EXP: 6/24/2014.
Code information SIMVASTATIN, Tablet, 20 mg has the following code Pedigree: W003580, EXP: 6/24/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[4106]
FDA event record
· Exact recall-number query on openFDA
drug · product 63 of 273
HYDROCHLOROTHIAZIDE Tablet, 12.5 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 16729018201
D-525-2014
Recall number D-525-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 100 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; HYDROCHLOROTHIAZIDE Tablet, 12.5 mg may be potentially mislabeled as chlordiazePOXIDE HCl, Capsule, 25 mg, NDC 00555015902, Pedigree: AD46333_4, EXP: 5/16/2014.
Code information HYDROCHLOROTHIAZIDE Tablet, 12.5 mg has the following code Pedigree: AD46414_25, EXP: 5/16/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[1841]
FDA event record
· Exact recall-number query on openFDA
drug · product 64 of 273
hydrALAZINE HCl Tablet, 100 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 23155000401
D-526-2014
Recall number D-526-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 400 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; hydrALAZINE HCl Tablet, 100 mg may be potentially mislabeled as DOXEPIN HCL, Capsule, 150 mg, NDC 49884022201, Pedigree: AD46312_10, EXP: 5/16/2014; DOCUSATE SODIUM, Capsule, 250 mg, NDC 00536375701, Pedigree: AD73652_1, EXP: 5/29/2014; LEVOTHYROXINE SODIUM, Tablet, 112 mcg, NDC 00378181101, Pedigree: AD30197_13, EXP: 5/9/2014.
Code information hydrALAZINE HCl Tablet, 100 mg has the following codes Pedigree: AD46312_13, EXP: 5/16/2014; Pedigree: AD73652_4, EXP: 5/29/2014; Pedigree: AD30197_7, EXP: 5/9/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[2667]
FDA event record
· Exact recall-number query on openFDA
drug · product 65 of 273
LEFLUNOMIDE Tablet, 10 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 23155004303
D-527-2014
Recall number D-527-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 60 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; LEFLUNOMIDE Tablet, 10 mg may be potentially mislabeled as DOXYCYCLINE HYCLATE, Capsule, 100 mg, NDC 00143314250, Pedigree: W002645, EXP: 6/5/2014; SEVELAMER CARBONATE, Tablet, 800 mg, NDC 58468013001, Pedigree: W002623, EXP: 6/4/2014.
Code information LEFLUNOMIDE Tablet, 10 mg has the following codes Pedigree: W002659, EXP: 6/5/2014; Pedigree: W002658, EXP: 6/4/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[3931]
FDA event record
· Exact recall-number query on openFDA
drug · product 66 of 273
metFORMIN HCl Tablet 500 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 23155010201
D-528-2014
Recall number D-528-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 100 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; metFORMIN HCl Tablet, 500 mg may be potentially mislabeled as OMEGA-3 FATTY ACID, Capsule, 1000 mg, NDC 40985022921, Pedigree: AD32742_1, EXP: 5/1/2014.
Code information metFORMIN HCl, Tablet 500 mg has the following code Pedigree: AD46312_25, EXP: 5/16/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[1606]
FDA event record
· Exact recall-number query on openFDA
drug · product 67 of 273
PROPRANOLOL HCL Tablet, 10 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 23155011001
D-529-2014
Recall number D-529-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 2,299 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; PROPRANOLOL HCL, Tablet, 10 mg may be potentially mislabeled as PERPHENAZINE, Tablet, 16 mg, NDC 00781104901, Pedigree: AD21790_31, EXP: 5/1/2014; buPROPion HCl ER (XL), Tablet, 150 mg, NDC 67767014130, Pedigree: AD52412_4, EXP: 4/30/2014; MULTIVITAMIN/MULTIMINERAL LOW IRON, Tablet, NDC 64376081601, Pedigree: AD60272_31, EXP: 5/22/2014; PERPHENAZINE, Tablet, 16 mg, NDC
Code information PROPRANOLOL HCL Tablet, 10 mg has the following codes Pedigree: AD21790_34, EXP: 5/1/2014; Pedigree: AD52390_1, EXP: 5/17/2014; Pedigree: AD60272_37, EXP: 5/22/2014; Pedigree: W002732, EXP: 6/6/2014; Pedigree: W003229, EXP: 6/17/2014; Pedigree: AD60272_34, EXP: 5/22/2014; Pedigree: W003684, EXP: 6/25/2014; Pedigree: W002618, EXP: 6/4/2014; Pedigree: W003002, EXP: 6/11/2014; Pedigree: W003068, EXP: 6/12/2014; Pedigree: W003545, EXP: 6/21/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[2736]
FDA event record
· Exact recall-number query on openFDA
drug · product 68 of 273
PROPRANOLOL HCL Tablet, 5 mg (1/2 of 10 mg), Rx only, Distributed by: AidaPak Service, LLC, NDC 23155011001
D-530-2014
Recall number D-530-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 198 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; PROPRANOLOL HCL Tablet, 5 mg (1/2 of 10 mg) may be potentially mislabeled as LITHIUM CARBONATE ER, Tablet, 225 mg (1/2 of 450 mg), NDC 00054002025, Pedigree: AD73525_16, EXP: 5/30/2014.
Code information PROPRANOLOL HCL, Tablet, 5 mg (1/2 of 10 mg) has the following code Pedigree: AD73525_25, EXP: 5/30/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[1842]
FDA event record
· Exact recall-number query on openFDA
drug · product 69 of 273
PROPRANOLOL HCL Tablet, 10 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 23155011010
D-531-2014
Recall number D-531-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 1,999 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; PROPRANOLOL HCL Tablet, 10 mg may be potentially mislabeled as LACTOBACILLUS ACIDOPHILUS, Capsule, NDC 54629011101, Pedigree: AD65311_4, EXP: 5/24/2014.
Code information PROPRANOLOL HCL Tablet, 10 mg has the following code Pedigree: AD65317_1, EXP: 5/24/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[4062]
FDA event record
· Exact recall-number query on openFDA
drug · product 70 of 273
PROPRANOLOL HCL Tablet, 80 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 23155011401
D-532-2014
Recall number D-532-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 100 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; PROPRANOLOL HCL Tablet, 80 mg may be potentially mislabeled as LACTOBACILLUS GG, Capsule, NDC 49100036374, Pedigree: AD42584_12, EXP: 5/14/2014.
Code information PROPRANOLOL HCL, Tablet, 80 mg has the following code Pedigree: AD42566_4, EXP: 5/14/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[2801]
FDA event record
· Exact recall-number query on openFDA
drug · product 71 of 273
ACARBOSE, Tablet 25 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 23155014701
D-533-2014
Recall number D-533-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 100 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; ACARBOSE Tablet, 25 mg may be potentially mislabeled as LACTOBACILLUS GG, Capsule, NDC 49100036374, Pedigree: AD39588_4, EXP: 5/13/2014.
Code information ACARBOSE Tablet, 25 mg has the following code Pedigree: AD32757_1, EXP: 5/13/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[3868]
FDA event record
· Exact recall-number query on openFDA
drug · product 72 of 273
VENLAFAXINE HCL Tablet, 50 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 23155024801
D-534-2014
Recall number D-534-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 100 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; VENLAFAXINE HCL Tablet, 50 mg may be potentially mislabeled as sulfaSALAzine, Tablet, 500 mg, NDC 00603580121, Pedigree: AD65475_19, EXP: 5/28/2014.
Code information VENLAFAXINE HCL Tablet, 50 mg has the following code Pedigree: AD65475_22, EXP; 5/28/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[3470]
FDA event record
· Exact recall-number query on openFDA
drug · product 73 of 273
MULTIVITAMIN/ MULTIMINERAL/ LUTEIN Capsule, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 24208063210
D-535-2014
Recall number D-535-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 204 Capsules
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; MULTIVITAMIN/ MULTIMINERAL/ LUTEIN Capsule may be potentially mislabeled as CAFFEINE, Tablet, 200 mg, NDC 24385060173, Pedigree: AD21846_37, EXP: 5/1/2014; CAFFEINE, Tablet, 200 mg, NDC 24385060173, Pedigree: AD60240_42, EXP: 5/22/2014; CAFFEINE, Tablet, 200 mg, NDC 24385060173, Pedigree: W003024, EXP: 6/12/2014; MELATONIN, Tablet, 3 mg, NDC 08770140813, Pedigree: AD73
Code information MULTIVITAMIN/ MULTIMINERAL/ LUTEIN Capsule has the following codes Pedigree: AD21846_40, EXP: 5/2/2014; Pedigree: AD60240_45, EXP: 5/22/2014; Pedigree: W003025, EXP: 6/12/2014; Pedigree: AD73521_37, EXP: 5/30/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[2798]
FDA event record
· Exact recall-number query on openFDA
drug · product 74 of 273
ERYTHROMYCIN DR EC Tablet, 250 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 24338012213
D-536-2014
Recall number D-536-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 100 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; ERYTHROMYCIN DR EC Tablet, 250 mg may be potentially mislabeled as methylPREDNISolone, Tablet, 4 mg, NDC 00781502201, Pedigree: AD46426_10, EXP: 5/15/2014.
Code information ERYTHROMYCIN DR EC Tablet, 250 mg has the following code Pedigree: AD46426_13, EXP: 5/15/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[2691]
FDA event record
· Exact recall-number query on openFDA
drug · product 75 of 273
LACTASE ENZYME Tablet, 3000 units, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 24385014976
D-537-2014
Recall number D-537-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 2,872 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; LACTASE ENZYME Tablet, 3000 units may be potentially mislabeled as BENZOCAINE/MENTHOL, LOZENGE, 15 mg/3.6 mg, NDC 63824072016, Pedigree: AD21811_4, EXP: 5/1/2014; ACETAMINOPHEN/ ASPIRIN/ CAFFEINE, Tablet, 250 mg/250 mg/65 mg, NDC 46122010478, Pedigree: W003722, EXP: 4/30/2014; guaiFENesin ER, Tablet, 600 mg, NDC 45802049878, Pedigree: AD30140_37, EXP: 5/7/2014; CALCIUM
Code information LACTASE ENZYME Tablet, 3000 units has the following codes Pedigree: AD21846_31, EXP: 5/1/2014; Pedigree: W003721, EXP: 6/26/2014; Pedigree: AD30028_25, EXP: 5/7/2014; Pedigree: AD60240_36, EXP: 5/22/2014; Pedigree: W002700, EXP: 6/5/2014; Pedigree: AD46257_53, EXP: 5/15/2014; Pedigree: W003021, EXP: 6/12/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[2757]
FDA event record
· Exact recall-number query on openFDA
drug · product 76 of 273
NICOTINE POLACRILEX Gum, 2 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 24385059471
D-538-2014
Recall number D-538-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 50 Pieces of Gum
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; NICOTINE POLACRILEX Gum, 2 mg may be potentially mislabeled as SACCHAROMYCES BOULARDII LYO, Capsule, 250 mg, NDC 00414200007, Pedigree: AD54586_4, EXP: 5/21/2014.
Code information NICOTINE POLACRILEX Gum, 2 mg has the following code Pedigree: AD54586_7, EXP: 3/31/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[2733]
FDA event record
· Exact recall-number query on openFDA
drug · product 77 of 273
PHYTONADIONE Tablet, 5 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 25010040515
D-539-2014
Recall number D-539-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 500 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; PHYTONADIONE Tablet, 5 mg may be potentially mislabeled as medroxyPROGESTERone ACETATE, Tablet, 10 mg, NDC 59762374202, Pedigree: AD46312_19, EXP: 5/16/2014; HYDROCORTISONE, Tablet, 5 mg, NDC 00603389919, Pedigree: W003060, EXP: 6/12/2014; GALANTAMINE HBR ER, Capsule, 24 mg, NDC 47335083783, Pedigree: W003735, EXP: 5/31/2014; TORSEMIDE, Tablet, 10 mg, NDC 31722053001,
Code information PHYTONADIONE Tablet, 5 mg has the following codes Pedigree: AD46312_22, EXP: 4/30/2014; Pedigree: W003061, EXP: 5/31/2014; Pedigree: W003737, EXP: 5/31/2014; Pedigree: AD25452_1, EXP: 4/30/2014; Pedigree: W003440, EXP: 5/31/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[2758]
FDA event record
· Exact recall-number query on openFDA
drug · product 78 of 273
CAFFEINE Tablet, 200 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 24385060173
D-540-2014
Recall number D-540-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 128 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; CAFFEINE Tablet, 200 mg may be potentially mislabeled as CALCIUM CITRATE, Tablet, 950 mg (200 mg ELEMENTAL Ca), NDC 00904506260, Pedigree: AD21846_24, EXP: 5/1/2014; CHOLECALCIFEROL, Capsule, 2000 units, NDC 00536379001, Pedigree: AD60240_4, EXP: 5/22/2014; FEXOFENADINE HCL, Tablet, 60 mg, NDC 45802042578, Pedigree: W003020, EXP: 6/12/2014; MELATONIN, Tablet, 3 mg, ND
Code information CAFFEINE Tablet, 200 mg has the following codes Pedigree: AD21846_37, EXP: 5/1/2014; Pedigree: AD60240_42, EXP: 5/22/2014; Pedigree: W003024, EXP: 6/12/2014; Pedigree: W003725, EXP: 6/26/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[1623]
FDA event record
· Exact recall-number query on openFDA
drug · product 79 of 273
PHYTONADIONE Tablet, 5 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 25010040515
D-541-2014
Recall number D-541-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 500 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; PHYTONADIONE Tablet, 5 mg may be potentially mislabeled as medroxyPROGESTERone ACETATE, Tablet, 10 mg, NDC 59762374202, Pedigree: AD46312_19, EXP: 5/16/2014; HYDROCORTISONE, Tablet, 5 mg, NDC 00603389919, Pedigree: W003060, EXP: 6/12/2014; GALANTAMINE HBR ER, Capsule, 24 mg, NDC 47335083783, Pedigree: W003735, EXP: 5/31/2014; TORSEMIDE, Tablet, 10 mg, NDC 31722053001,
Code information PHYTONADIONE Tablet, 5 mg has the following codes Pedigree: AD46312_22, EXP: 4/30/2014; Pedigree: W003061, EXP: 5/31/2014; Pedigree: W003737, EXP: 5/31/2014; Pedigree: AD25452_1, EXP: 4/30/2014; Pedigree: W003440, EXP: 5/31/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[1250]
FDA event record
· Exact recall-number query on openFDA
drug · product 80 of 273
BISOPROLOL FUMARATE Tablet, 5 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 29300012601
D-542-2014
Recall number D-542-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 299 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; BISOPROLOL FUMARATE Tablet, 5 mg may be potentially mislabeled as: ESTROPIPATE, Tablet, 0.75 mg, NDC 00591041401, Pedigree: AD34934_4, EXP: 5/10/2014.
Code information BISOPROLOL FUMARATE Tablet, 5 mg has the following code Pedigree: AD34934_7, EXP: 5/10/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[1579]
FDA event record
· Exact recall-number query on openFDA
drug · product 81 of 273
CRANBERRY EXTRACT/VITAMIN C Capsule, 450 mg/125 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 31604014271
D-543-2014
Recall number D-543-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 546 Capsules
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; CRANBERRY EXTRACT/VITAMIN C Capsule, 450 mg/125 mg may be potentially mislabeled as MULTIVITAMIN/MULTIMINERAL, Tablet, NDC 00536406001, Pedigree: W002653, EXP: 6/5/2014; MODAFINIL, Tablet, 200 mg, NDC 00603466216, Pedigree: W003779, EXP: 6/26/2014; NIACIN ER, Tablet, 500 mg, NDC 00074307490, Pedigree: W003739, EXP: 6/26/2014; GLUCOSAMINE/CHONDROITIN, Capsule, 500 mg/40
Code information CRANBERRY EXTRACT/VITAMIN C Capsule, 450 mg/125 mg has the following codes Pedigree: W002692, EXP: 6/5/2014; Pedigree: W003715, EXP: 6/26/2014; Pedigree: W003716, EXP: 6/26/2014; Pedigree: AD60240_11, EXP: 5/22/2014; Pedigree: W002693, EXP: 6/5/2014; Pedigree: AD46257_13, EXP: 5/15/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[1807]
FDA event record
· Exact recall-number query on openFDA
drug · product 82 of 273
QUINAPRIL Tablet, 40 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 31722027090
D-544-2014
Recall number D-544-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 90 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; QUINAPRIL Tablet, 40 mg may be potentially mislabeled as PROPRANOLOL HCL, Tablet, 10 mg, NDC 16714002104, Pedigree: AD52778_73, EXP: 5/21/2014.
Code information QUINAPRIL Tablet, 40 mg has the following code Pedigree: AD52778_76, EXP: 5/21/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[2812]
FDA event record
· Exact recall-number query on openFDA
drug · product 83 of 273
TORSEMIDE Tablet, 10 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 31722053001
D-545-2014
Recall number D-545-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 100 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; TORSEMIDE Tablet, 10 mg may be potentially mislabeled as MEXILETINE HCL, Capsule, 200 mg, NDC 00093874001, Pedigree: AD25264_7, EXP: 5/3/2014.
Code information TORSEMIDE Tablet, 10 mg has the following code Pedigree: AD25264_13, EXP: 5/3/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[3637]
FDA event record
· Exact recall-number query on openFDA
drug · product 84 of 273
MAGNESIUM GLUCONATE Tablet, 500 mg (27 mg Elem Mg), Over The Counter, Distributed by: AidaPak Service, LLC, NDC 35046000322
D-546-2014
Recall number D-546-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 90 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; MAGNESIUM GLUCONATE Tablet, 500 mg (27 mg Elem Mg) may be potentially mislabeled as FLUVASTATIN, Capsule, 20 mg, NDC 00378802077, Pedigree: W002655, EXP: 6/4/2014.
Code information MAGNESIUM GLUCONATE Tablet, 500 mg (27 mg Elem Mg) has the following code Pedigree: W002687, EXP: 6/5/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[2777]
FDA event record
· Exact recall-number query on openFDA
drug · product 85 of 273
MELATONIN Tablet, 1 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 35046000391
D-547-2014
Recall number D-547-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 200 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; MELATONIN Tablet, 1 mg may be potentially mislabeled as CRANBERRY EXTRACT/VITAMIN C, Capsule, 450 mg/125 mg, NDC 31604014271, Pedigree: W002692, EXP: 6/5/2014; GLYCOPYRROLATE, Tablet, 2 mg, NDC 00603318121, Pedigree: W003252, EXP: 6/17/2014.
Code information MELATONIN Tablet, 1 mg has the following codes Pedigree: W002695, EXP: 6/5/2014; Pedigree: W003317, EXP: 6/18/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[2772]
FDA event record
· Exact recall-number query on openFDA
drug · product 86 of 273
MULTIVITAMIN/MULTIMINERAL Tablet, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 37205018581
D-548-2014
Recall number D-548-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 1,045 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; MULTIVITAMIN/MULTIMINERAL, Tablet may be potentially mislabeled as QUEtiapine FUMARATE, Tablet, 25 mg, NDC 60505313001, Pedigree: AD33897_25, EXP: 5/9/2014; DOCUSATE SODIUM, Capsule, 250 mg, NDC 00536375710, Pedigree: W002512, EXP: 6/3/2014.
Code information MULTIVITAMIN/MULTIMINERAL Tablet has the following codes Pedigree: AD32328_8, EXP: 5/9/2014; Pedigree: W002513, EXP: 6/3/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[3636]
FDA event record
· Exact recall-number query on openFDA
drug · product 87 of 273
COENZYME Q-10, Capsule 100 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 37205055065
D-549-2014
Recall number D-549-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 341 Capsules
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; COENZYME Q-10 Capsule, 100 mg may be potentially mislabeled as ASPIRIN EC, Tablet, 325 mg, NDC 00904201360, Pedigree: AD30180_13, EXP: 5/9/2014; ASPIRIN, Chew Tablet, 81 mg, NDC 00536329736, Pedigree: AD33897_1, EXP: 5/9/2014; TACROLIMUS, Capsule, 1 mg, NDC 00781210301, Pedigree: AD37056_1, EXP: 5/10/2014; METOPROLOL TARTRATE, Tablet, 12.5 mg (1/2 of 25 mg), NDC 576640
Code information COENZYME Q-10, Capsule, 100 mg has the following codes Pedigree: AD30180_16, EXP: 5/9/2014; Pedigree: AD32325_4, EXP: 5/9/2014; Pedigree: AD37056_4, EXP: 5/10/2014; Pedigree: AD70655_11, EXP: 5/28/2014; Pedigree: W002711, EXP: 6/6/2014; Pedigree: W003871, EXP: 6/27/2014; Pedigree: W003998, EXP: 7/1/2014; Pedigree: AD68019_4, EXP: 5/28/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[3651]
FDA event record
· Exact recall-number query on openFDA
drug · product 88 of 273
NICOTINE POLACRILEX Lozenge, 2 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 37205098769
D-550-2014
Recall number D-550-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 1,582 Lozenges
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; NICOTINE POLACRILEX Lozenge, 2 mg may be potentially mislabeled as ASPIRIN DR EC, Tablet, 81 mg, NDC 00182106105, Pedigree: AD52433_1, EXP: 5/17/2014; chlorproMAZINE HCl, Tablet, 100 mg, NDC 00832030300, Pedigree: AD70700_1, EXP: 5/29/2014; CALCIUM ACETATE, Capsule, 667 mg, NDC 00054008826, Pedigree: AD73623_1, EXP: 5/30/2014; FOLIC ACID, Tablet, 1 mg, NDC 65162036110,
Code information NICOTINE POLACRILEX Lozenge, 2 mg has the following codes Pedigree: AD52433_4, EXP: 5/17/2014; Pedigree: AD70700_4, EXP: 5/29/2014; Pedigree: AD73623_7, EXP: 5/30/2014; Pedigree: W003823, EXP: 6/27/2014; Pedigree: W003463, EXP: 6/20/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[1588]
FDA event record
· Exact recall-number query on openFDA
drug · product 89 of 273
VITAMIN B COMPLEX PROLONGED RELEASE Tablet, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 40985022251
D-551-2014
Recall number D-551-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 120 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; VITAMIN B COMPLEX PROLONGED RELEASE Tablet may be potentially mislabeled as guaiFENesin ER, Tablet, 600 mg, NDC 63824000815, Pedigree: AD73627_23, EXP: 5/30/2014; TOLTERODINE TARTRATE ER, Capsule, 4 mg, NDC 00009519101, Pedigree: AD73686_1, EXP: 5/31/2014.
Code information VITAMIN B COMPLEX PROLONGED RELEASE Tablet has the following codes Pedigree: AD73627_26, EXP: 5/30/2014; Pedigree: AD76686_1, EXP: 5/31/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[2793]
FDA event record
· Exact recall-number query on openFDA
drug · product 90 of 273
VITAMIN B COMPLEX PROLONGED RELEASE Tablet, 50 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 40985022251
D-552-2014
Recall number D-552-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 182 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; VITAMIN B COMPLEX PROLONGED RELEASE, Tablet, 50 mg may be potentially mislabeled as COENZYME Q-10, Capsule, 100 mg, NDC 37205055065, Pedigree: AD30180_16, EXP: 5/9/2014; DOCUSATE SODIUM, Capsule, 50 mg, NDC 67618010060, Pedigree: AD60211_8, EXP: 5/21/2014; ASPIRIN EC, Tablet, 325 mg, NDC 00904201360, Pedigree: AD39588_1, EXP: 5/13/2014.
Code information VITAMIN B COMPLEX PROLONGED RELEASE Tablet, 50 mg has the following codes Pedigree: AD30180_19, EXP: 5/9/2014; Pedigree: AD60211_20, EXP: 5/21/2014; Pedigree: AD39588_10, EXP: 5/13/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[3592]
FDA event record
· Exact recall-number query on openFDA
drug · product 91 of 273
OMEGA-3 FATTY ACID Capsule, 1000 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 40985022921
D-553-2014
Recall number D-553-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 36,840 Capsules
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; OMEGA-3 FATTY ACID Capsule, 1000 mg may be potentially mislabeled as PYRIDOXINE HCL, Tablet, 50 mg, NDC 00904052060, Pedigree: AD22865_19, EXP: 5/2/2014; CHOLECALCIFEROL, Capsule, 2000 units, NDC 00536379001, Pedigree: AD30028_7, EXP: 5/8/2014; DOCUSATE SODIUM, Capsule, 250 mg, NDC 00536375710, Pedigree: W003054, EXP: 6/12/2014; CHOLECALCIFEROL, Capsule, 2000 units, ND
Code information OMEGA-3 FATTY ACID Capsule, 1000 mg has the following codes Pedigree: AD21846_1, EXP: 5/1/2014; Pedigree: AD30028_4, EXP: 5/8/2014; Pedigree: W003015, EXP: 6/12/2014; Pedigree: W003710, EXP: 6/26/2014; Pedigree: W003711, EXP: 6/26/2014; Pedigree: AD46257_1, EXP: 5/15/2014; Pedigree: W002965, EXP: 6/10/2014; Pedigree: W003312, EXP: 6/18/2014; Pedigree: AD30028_1, EXP: 5/8/2014; Pedigree: AD46257_4, EXP: 5/15/2014; Pedigree: AD32742_1, EXP: 5/1/2014; Pedigree: AD60240_1, EXP: 5/22/2014; Pedigree: ADWA00002135, EXP: 5/31/2014; Pedigree: W002690, EXP: 6/5/2014; Pedigree: W003313, EXP: 6/18/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[2699]
FDA event record
· Exact recall-number query on openFDA
drug · product 92 of 273
FEXOFENADINE HCL, Tablet 180 mg, Rx only, Distributed by: AidaPak Service, LLC,NDC 41167412003
D-554-2014
Recall number D-554-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 30 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; FEXOFENADINE HCL Tablet, 180 mg may be potentially mislabeled as MULTIVITAMIN/MULTIMINERAL, Tablet, NDC 00536406001, Pedigree: AD62992_8, EXP: 5/23/2014.
Code information FEXOFENADINE HCL, Tablet, 180 mg has the following code Pedigree: AD62834_1, EXP: 5/23/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[3577]
FDA event record
· Exact recall-number query on openFDA
drug · product 93 of 273
LEVOTHYROXINE/ LIOTHYRONINE Tablet, 19 mcg/4.5 mcg, Rx only, Distributed by: AidaPak Service, LLC, NDC 42192032901
D-555-2014
Recall number D-555-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 102 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; LEVOTHYROXINE/ LIOTHYRONINE Tablet, 19 mcg/4.5 mcg may be potentially mislabeled as MAGNESIUM GLUCONATE DIHYDRATE, Tablet, 500 mg (27 mg Elemental Magnesium), NDC 60258017201, Pedigree: AD30197_16, EXP: 5/9/2014.
Code information LEVOTHYROXINE/ LIOTHYRONINE Tablet, 19 mcg/4.5 mcg has the following code Pedigree: AD30197_19, EXP: 3/31/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[3459]
FDA event record
· Exact recall-number query on openFDA
drug · product 94 of 273
LIOTHYRONINE SODIUM, Tablet, 5 mcg, Rx only, Distributed by: AidaPak Service, LLC, NDC 42794001802
D-556-2014
Recall number D-556-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 100 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; LIOTHYRONINE SODIUM Tablet, 5 mcg may be potentially mislabeled as HYDROCHLOROTHIAZIDE, Tablet, 12.5 mg, NDC 16729018201, Pedigree: AD46414_25, EXP: 5/16/2014.
Code information LIOTHYRONINE SODIUM Tablet, 5 mcg has the following code Pedigree: AD46414_38, EXP: 5/16/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[2687]
FDA event record
· Exact recall-number query on openFDA
drug · product 95 of 273
LIOTHYRONINE SODIUM, Tablet 25 mcg, Rx only, Distributed by: AidaPak Service, LLC, NDC 42794001902
D-557-2014
Recall number D-557-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 200 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; LIOTHYRONINE SODIUM Tablet, 25 mcg may be potentially mislabeled as guanFACINE HCl, Tablet, 1 mg, NDC 00378116001, Pedigree: AD46414_22, EXP: 5/16/2014; BROMOCRIPTINE MESYLATE, Tablet, 2.5 mg, NDC 00574010603, Pedigree: AD68010_4, EXP: 5/28/2014.
Code information LIOTHYRONINE SODIUM Tablet, 25 mcg has the following codes Pedigree: AD46414_35, EXP: 5/16/2014; Pedigree: AD68010_11, EXP: 5/28/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[2824]
FDA event record
· Exact recall-number query on openFDA
drug · product 96 of 273
PANCRELIPASE DR Capsule, Rx only, Distributed by: AidaPak Service, LLC, NDC 42865010302
D-558-2014
Recall number D-558-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 200 Capsules
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; PANCRELIPASE DR Capsule may be potentially mislabeled as MELATONIN, Tablet, 1 mg, NDC 35046000391, Pedigree: W003317, EXP: 6/18/2014; VERAPAMIL HCL, Tablet, 40 mg, NDC 00591040401, Pedigree: W003170, EXP: 6/13/2014.
Code information PANCRELIPASE DR, Capsule has the following codes Pedigree: W003354, EXP: 6/19/2014; Pedigree: W003171, EXP: 6/13/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[3479]
FDA event record
· Exact recall-number query on openFDA
drug · product 97 of 273
HYOSCYAMINE SULFATE ER, Tablet, 0.375 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 43199001401
D-559-2014
Recall number D-559-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 99 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; HYOSCYAMINE SULFATE ER Tablet, 0.375 mg may be potentially mislabeled as SERTRALINE HCL, Tablet, 50 mg, NDC 16714061204, Pedigree: W003575, EXP: 6/24/2014.
Code information HYOSCYAMINE SULFATE ER Tablet, 0.375 mg has the following code Pedigree: W003576, EXP: 6/24/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[1866]
FDA event record
· Exact recall-number query on openFDA
drug · product 98 of 273
LACTOBACILLUS ACIDOPHILUS Capsule, 500 Million CFU, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 43292050022
D-560-2014
Recall number D-560-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 700 Capsules
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; LACTOBACILLUS ACIDOPHILUS, Capsule, 500 Million CFU may be potentially mislabeled as MELATONIN, Tablet, 3 mg, NDC 08770140813, Pedigree: AD46257_56, EXP: 5/15/2014; MELATONIN, Tablet, 3 mg, NDC 08770140813, Pedigree: AD30028_28, EXP: 5/7/2014; CRANBERRY EXTRACT/VITAMIN C, Capsule, 450 mg/125 mg, NDC 31604014271, Pedigree: AD60240_11, EXP: 5/22/2014.
Code information LACTOBACILLUS ACIDOPHILUS Capsule, 500 Million CFU has the following codes Pedigree: AD46257_28, EXP: 5/15/2014; Pedigree: AD30028_10, EXP: 5/7/2014; Pedigree: AD60240_20, EXP: 5/22/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[2805]
FDA event record
· Exact recall-number query on openFDA
drug · product 99 of 273
VITAMIN B COMPLEX, Tablet Over The Counter, Distributed by: AidaPak Service, LLC, NDC 43292055540
D-561-2014
Recall number D-561-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 200 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; VITAMIN B COMPLEX Tablet may be potentially mislabeled as OMEPRAZOLE/SODIUM BICARBONATE, Capsule, 20 mg/1,100 mg, NDC 11523726503, Pedigree: W003789, EXP: 6/27/2014; prednisoLONE, Tablet, 5 mg, NDC 16477050501, Pedigree: W003627, EXP: 6/25/2014.
Code information VITAMIN B COMPLEX, Tablet has the following codes Pedigree: W003820, EXP: 6/27/2014; Pedigree: W003628, EXP: 6/25/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[3918]
FDA event record
· Exact recall-number query on openFDA
Recall number D-562-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 999 Capsules
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; LACTOBACILLUS ACIDOPHILUS, Capsule, 500 Million CFU may be potentially mislabeled as DOCUSATE SODIUM, Capsule, 250 mg, NDC 00536375710, Pedigree: W002694, EXP: 6/5/2014
Code information LACTOBACILLUS ACIDOPHILUS, Capsule, 500 Million CFU has the following code Pedigree: W002698, EXP: 6/5/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[3642]
FDA event record
· Exact recall-number query on openFDA
Recall number D-563-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 112 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; METHYLERGONOVINE MALEATE Tablet, 0.2 mg may be potentially mislabeled as ISOSORBIDE MONONITRATE, Tablet, 20 mg, NDC 62175010701, Pedigree: AD52778_31, EXP: 5/20/2014; LEVOTHYROXINE SODIUM, Tablet, 88 mcg, NDC 00378180701, Pedigree: W003476, EXP: 6/20/2014.
Code information METHYLERGONOVINE MALEATE, Tablet, 0.2 mg has the following codes Pedigree: AD52778_40, EXP: 5/20/2014; Pedigree: W003477, EXP: 6/20/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[1270]
FDA event record
· Exact recall-number query on openFDA
Recall number D-564-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 120 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; MISOPROSTOL Tablet, 100 mcg may be potentially mislabeled as QUINAPRIL HCL, Tablet, 10 mg, NDC 59762502001, Pedigree: AD42611_4, EXP: 5/14/2014.
Code information MISOPROSTOL, Tablet, 100 mcg has the following code Pedigree: AD42611_7, EXP: 5/14/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[3455]
FDA event record
· Exact recall-number query on openFDA
Recall number D-565-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 202 Capsules
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; NIFEDIPINE Capsule, 10 mg may be potentially mislabeled as MULTIVITAMIN/MULTIMINERAL W/FLUORIDE, Chew Tablet, 1 mg (F), NDC 64376081501, Pedigree: AD22609_7, EXP: 5/2/2014; NIFEDIPINE, Capsule, 10 mg, NDC 43386044024, Pedigree: AD23082_7, EXP: 9/23/2013.
Code information NIFEDIPINE, Capsule, 10 mg has the following codes Pedigree: AD23082_7, EXP: 9/23/2013; Pedigree: AD23082_10, EXP: 9/23/2013.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[1274]
FDA event record
· Exact recall-number query on openFDA
Recall number D-566-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 100 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; ORPHENADRINE CITRATE ER Tablet, 100 mg may be potentially mislabeled as OMEGA-3 FATTY ACID, Capsule, 1000 mg, NDC 40985022921, Pedigree: W002965, EXP: 6/10/2014.
Code information ORPHENADRINE CITRATE ER, Tablet, 100 mg has the folowing code Pedigree: W002962, EXP: 6/11/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[4067]
FDA event record
· Exact recall-number query on openFDA
Recall number D-567-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 200 Capsules
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; ISOMETHEPTENE MUCATE/ DICHLORALPHENAZONE/APAP Capsule, 65 mg/100 mg/325 mg may be potentially mislabeled as ALBUTEROL SULFATE ER, Tablet, 4 mg, NDC 00378412201, Pedigree: W003578, EXP: 6/24/2014; LOSARTAN POTASSIUM, Tablet, 25 mg, NDC 16714058102, Pedigree: AD22616_7, EXP: 5/2/2014.
Code information ISOMETHEPTENE MUCATE/ DICHLORALPHENAZONE/APAP, Capsule, 65 mg/100 mg/325 mg has the following codes Pedigree: W003596, EXP: 5/31/2014; Pedigree: AD22858_1, EXP: 3/31/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[3894]
FDA event record
· Exact recall-number query on openFDA
Recall number D-568-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 300 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; FEXOFENADINE HCL Tablet, 60 mg may be potentially mislabeled as PYRIDOXINE HCL, Tablet, 50 mg, NDC 51645090901, Pedigree: W003019, EXP: 6/12/2014; NIACIN TR, Capsule, 500 mg, NDC 00904063160, Pedigree: AD60240_17, EXP: 5/22/2014; CRANBERRY EXTRACT/VITAMIN C, Capsule, 450 mg/125 mg, NDC 31604014271, Pedigree: AD46257_13, EXP: 5/15/2014.
Code information FEXOFENADINE HCL Tablet, 60 mg has the following codes Pedigree: W003020, EXP: 6/12/2014; Pedigree: AD60240_30, EXP: 5/22/2014; Pedigree: AD46257_50, EXP: 5/15/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[3569]
FDA event record
· Exact recall-number query on openFDA
Recall number D-569-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 500 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; guaiFENesin ER, Tablet, 600 mg may be potentially mislabeled as FENOFIBRATE, Tablet, 54 mg, NDC 00378710077, Pedigree: AD21790_52, EXP: 5/1/2014; FENOFIBRATE, Tablet, 54 mg, NDC 00378710077, Pedigree: W002733, EXP: 6/6/2014; glyBURIDE, Tablet, 2.5 mg, NDC 00093834301, Pedigree: W003688, EXP: 5/31/2014; glyBURIDE, Tablet, 2.5 mg, NDC 00093834301, Pedigree: AD30140_34, E
Code information guaiFENesin ER, Tablet, 600 mg has the following codes Pedigree: AD21790_58, EXP: 5/1/2014; Pedigree: W002734, EXP: 6/6/2014; Pedigree: W003689, EXP: 6/26/2014; Pedigree: AD30140_37, EXP: 5/7/2014; Pedigree: W003006, EXP: 6/11/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[2823]
FDA event record
· Exact recall-number query on openFDA
Recall number D-570-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 799 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; LORATADINE Tablet, 10 mg may be potentially mislabeled as GLYCOPYRROLATE, Tablet, 2 mg, NDC 00603318121, Pedigree: W002650, EXP: 6/5/2014; OMEGA-3 FATTY ACID, Capsule, 1000 mg, NDC 05445800022, Pedigree: AD21858_4, EXP: 5/1/2014; OMEGA-3 FATTY ACID, Capsule, 1000 mg, NDC 00904404360, Pedigree: W003217, EXP: 6/14/2014.
Code information LORATADINE, Tablet, 10 mg has the following codes Pedigree: W002652, EXP: 6/5/2014; Pedigree: AD22865_7, EXP: 5/2/2014; Pedigree: W003253, EXP: 6/17/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[2808]
FDA event record
· Exact recall-number query on openFDA
Recall number D-571-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 98 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; DESIPRAMINE HCL Tablet, 50 mg may be potentially mislabeled as clomiPRAMINE HCl, Capsule, 50 mg, NDC 51672401205, Pedigree: AD30140_4, EXP: 5/7/2014.
Code information DESIPRAMINE HCL, Tablet, 50 mg has the following code Pedigree: AD30140_7, EXP: 5/7/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[3431]
FDA event record
· Exact recall-number query on openFDA
Recall number D-572-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 100 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; ACETAMINOPHEN/ ASPIRIN/ CAFFEINE, Tablet, 250 mg/250 mg/65 mg may be potentially mislabeled as MULTIVITAMIN/MULTIMINERAL, Chew Tablet, NDC 00536344308, Pedigree: W003714, EXP: 6/26/2014.
Code information ACETAMINOPHEN/ ASPIRIN/ CAFFEINE, Tablet, 250 mg/250 mg/65 mg has the following code Pedigree: W003722, EXP: 4/30/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[2787]
FDA event record
· Exact recall-number query on openFDA
Recall number D-573-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 60 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; buPROPion HCl ER Tablet, 200 mg may be potentially mislabeled as AMANTADINE HCL, Capsule, 100 mg, NDC 00781204801, Pedigree: W002726, EXP: 6/6/2014.
Code information buPROPion HCl ER, Tablet, 200 mg has the following code Pedigree: W002727, EXP: 6/6/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[2803]
FDA event record
· Exact recall-number query on openFDA
Recall number D-574-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 30 Capsules
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; GALANTAMINE HBR ER, Capsule, 24 mg may be potentially mislabeled as ESCITALOPRAM, Tablet, 5 mg, NDC 00093585001, Pedigree: W003733, EXP: 6/26/2014.
Code information GALANTAMINE HBR ER, Capsule, 24 mg has the following code Pedigree: W003735, EXP: 5/31/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[2804]
FDA event record
· Exact recall-number query on openFDA
Recall number D-575-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 200 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; QUETIAPINE FUMARATE Tablet, 12.5 mg (1/2 of 25 mg) may be potentially mislabeled as SIMVASTATIN, Tablet, 40 mg, NDC 00093715598, Pedigree: AD22845_4, EXP: 5/2/2014.
Code information QUETIAPINE FUMARATE, Tablet, 12.5 mg (1/2 of 25 mg) has the following code Pedigree: AD21790_79, EXP: 5/1/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[3678]
FDA event record
· Exact recall-number query on openFDA
Recall number D-576-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 360 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; MELATONIN, Tablet, 1 mg may be potentially mislabeled as hydrOXYzine PAMOATE, Capsule, 100 mg, NDC 00555032402, Pedigree: AD46265_28, EXP: 5/15/2014; GLUCOSAMINE/CHONDROITIN DS, Tablet, 500 mg/400 mg, NDC 00904559293, Pedigree: AD60211_17, EXP: 5/22/2014.
Code information MELATONIN, Tablet, 1 mg has the following codes Pedigree: AD46257_19, EXP: 5/15/2014; Pedigree: AD60240_14, EXP: 5/22/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[3688]
FDA event record
· Exact recall-number query on openFDA
Recall number D-577-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 100 Capsules
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; NITROFURANTOIN MONOHYDRATE/ MACROCRYSTALS, Capsule, 100 mg may be potentially mislabeled as MINOCYCLINE HCL, Capsule, 50 mg, NDC 00591569401, Pedigree: AD52778_46, EXP: 5/20/2014.
Code information NITROFURANTOIN MONOHYDRATE/ MACROCRYSTALS, Capsule, 100 mg has the following code Pedigree: AD52778_58, EXP: 5/20/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[3879]
FDA event record
· Exact recall-number query on openFDA
Recall number D-578-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 102 Capsules
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; NITROFURANTOIN MACROCRYSTALS Capsule, 50 mg may be potentially mislabeled as PHYTONADIONE, Tablet, 5 mg, NDC 25010040515, Pedigree: AD25452_1, EXP: 4/30/2014.
Code information NITROFURANTOIN MACROCRYSTALS, Capsule, 50 mg has the following code Pedigree: AD25452_4, EXP: 5/3/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[4094]
FDA event record
· Exact recall-number query on openFDA
Recall number D-579-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 1,970 Capsules
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; LACTOBACILLUS GG Capsule may be potentially mislabeled as VITAMIN B COMPLEX W/C, Capsule, NDC 54629008001, Pedigree: AD39560_4, EXP: 5/13/2014; DOCUSATE SODIUM, Capsule, 50 mg, NDC 67618010060, Pedigree: AD65457_13, EXP: 5/24/2014; VITAMIN B COMPLEX WITH C/FOLIC ACID, Tablet, NDC 60258016001, Pedigree: AD70655_17, EXP: 5/28/2014; TACROLIMUS, Capsule, 1 mg, NDC 00781210
Code information LACTOBACILLUS GG, Capsule has the following codes Pedigree: AD39588_4, EXP: 5/13/2014 Pedigree: AD65457_16, EXP: 5/24/2014 Pedigree: AD70655_8, EXP: 5/29/2014 Pedigree: AD73627_17, EXP: 5/30/2014 Pedigree: W003051, EXP: 6/12/2014 Pedigree: W003216, EXP: 6/14/2014 Pedigree: AD42584_12, EXP: 5/14/2014 Pedigree: AD46300_11, EXP: 5/15/2014 Pedigree: W002968, EXP: 6/11/2014 Pedigree: AD68019_1, EXP: 5/28/2014 Pedigree: W003172, EXP: 6/13/2014 Pedigree: W003173, EXP: 6/13/2014
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[3916]
FDA event record
· Exact recall-number query on openFDA
Recall number D-580-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 300 Cells
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; LACTOBACILLUS GG Capsule, 10 Billion Cells may be potentially mislabeled as guaiFENesin ER, Tablet, 600 mg, NDC 63824000815, Pedigree: AD21965_22, EXP: 5/1/2014.
Code information LACTOBACILLUS GG, Capsule, 10 Billion Cells has the following code Pedigree: AD21965_19, EXP: 5/1/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[3649]
FDA event record
· Exact recall-number query on openFDA
Recall number D-581-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 630 Cells
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; LACTOBACILLUS GG Capsule, 15 Billion Cells may be potentially mislabeled as ASPIRIN EC, Tablet, 325 mg, NDC 00904201360, Pedigree: W003356, EXP: 6/19/2014; ZONISAMIDE, Capsule, 100 mg, NDC 64679099001, Pedigree: W003786, EXP: 6/27/2014; VENLAFAXINE HCL, Tablet, 25 mg, NDC 00093019901, Pedigree: W003860, EXP: 6/27/2014.
Code information LACTOBACILLUS GG, Capsule, 15 Billion Cells has the following codes Pedigree: W003357, EXP: 6/19/2014; Pedigree: W003787, EXP: 6/27/2014; Pedigree: W003869, EXP: 6/27/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[3670]
FDA event record
· Exact recall-number query on openFDA
Recall number D-582-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 300 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; ASPIRIN Tablet, 325 mg may be potentially mislabeled as CHOLECALCIFEROL, Tablet, 400 units, NDC 00904582360, Pedigree: W002642, EXP: 6/4/2014.
Code information ASPIRIN, Tablet, 325 mg has the following code Pedigree: W002640, EXP: 6/4/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[2749]
FDA event record
· Exact recall-number query on openFDA
Recall number D-583-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 107 Capsules
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; D-ALPHA TOCOPHERYL ACETATE Capsule, 400 units may be potentially mislabeled as CYANOCOBALAMIN, Tablet, 500 mcg, NDC 00536355101, Pedigree: AD52993_19, EXP: 5/20/2014.
Code information D-ALPHA TOCOPHERYL ACETATE, Capsule, 400 units has the following code Pedigree: AD52993_28, EXP: 5/20/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[4072]
FDA event record
· Exact recall-number query on openFDA
Recall number D-584-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 70 Lozenges
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; NICOTINE POLACRILEX Lozenge, 2 mg may be potentially mislabeled as VITAMIN B COMPLEX WITH C/FOLIC ACID, Tablet, NDC 60258016001, Pedigree: W003361, EXP: 6/19/2014.
Code information NICOTINE POLACRILEX, Lozenge, 2 mg has the following code Pedigree: W003393, EXP: 6/19/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[3875]
FDA event record
· Exact recall-number query on openFDA
Recall number D-585-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 544 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; ASPIRIN EC DR Tablet, 81 mg may be potentially mislabeled as MELATONIN, Tablet, 3 mg, NDC 51991001406, Pedigree: AD28322_7, EXP: 5/6/2014; DOCUSATE SODIUM, Capsule, 250 mg, NDC 00904789159, Pedigree: W003671, EXP: 6/25/2014.
Code information ASPIRIN EC DR, Tablet, 81 mg has the following codes Pedigree: AD28349_1, EXP: 2/28/2014; Pedigree: W003672, EXP: 2/28/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[2826]
FDA event record
· Exact recall-number query on openFDA
Recall number D-586-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 100 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; GLYCOPYRROLATE Tablet, 2 mg may be potentially mislabeled as LACTOBACILLUS, Tablet, NDC 64980012950, Pedigree: W003624, EXP: 1/31/2014.
Code information GLYCOPYRROLATE, Tablet, 2 mg has the following code Pedigree: W003625, EXP: 6/25/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[3616]
FDA event record
· Exact recall-number query on openFDA
Recall number D-587-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 100 Capsules
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; DOXEPIN HCL Capsule, 150 mg may be potentially mislabeled as VALSARTAN, Tablet, 160 mg, NDC 00078035934, Pedigree: AD46312_7, EXP: 5/16/2014.
Code information DOXEPIN HCL, Capsule, 150 mg has the following code Pedigree: AD46312_10, EXP: 5/16/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[3908]
FDA event record
· Exact recall-number query on openFDA
Recall number D-588-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 799 Capsules
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; DOXYCYCLINE MONOHYDRATE Capsule, 100 mg may be potentially mislabeled as diphenhydrAMINE HCl, Tablet, 25 mg, NDC 00904555159, Pedigree: AD67992_4, EXP: 5/28/2014; DUTASTERIDE, Capsule, 0.5 mg, NDC 00173071215, Pedigree: AD52778_4, EXP: 5/20/2014.
Code information DOXYCYCLINE MONOHYDRATE, Capsule, 100 mg has the following codes Pedigree: AD65323_7, EXP: 5/28/2014; Pedigree: AD52778_25, EXP: 5/20/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[2774]
FDA event record
· Exact recall-number query on openFDA
Recall number D-589-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 180 Capsules
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; DILTIAZEM HCL ER Capsule, 240 mg may be potentially mislabeled as NICOTINE POLACRILEX, Lozenge, 2 mg, NDC 37205098769, Pedigree: AD52433_4, EXP: 5/17/2014; PARoxetine HCl, Tablet, 10 mg, NDC 13107015430, Pedigree: AD52778_67, EXP: 5/20/2014.
Code information DILTIAZEM HCL ER, Capsule, 240 mg has the following codes Pedigree: AD52375_1, EXP: 5/17/2014; Pedigree: AD56917_1, EXP: 5/21/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[2795]
FDA event record
· Exact recall-number query on openFDA
Recall number D-590-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 100 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; HYDRALAZINE HCL Tablet, 25 mg may be potentially mislabeled as DOCUSATE CALCIUM, Capsule, 240 mg, NDC 00536375501, Pedigree: AD49582_16, EXP: 5/16/2014.
Code information HYDRALAZINE HCL, Tablet, 25 mg has the following code Pedigree: AD49610_4, EXP: 5/16/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[3615]
FDA event record
· Exact recall-number query on openFDA
Recall number D-591-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 100 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; hydrALAZINE HCl Tablet, 50 mg may be potentially mislabeled as CapsuleTOPRIL, Tablet, 12.5 mg, NDC 00143117101, Pedigree: AD52778_16, EXP: 5/20/2014.
Code information hydrALAZINE HCl, Tablet, 50 mg has the following code Pedigree: AD52778_28, EXP: 5/20/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[3644]
FDA event record
· Exact recall-number query on openFDA
Recall number D-592-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 400 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; traZODone HCl Tablet, 50 mg may be potentially mislabeled as DEXAMETHASONE, Tablet, 1 mg, NDC 00054418125, Pedigree: AD37088_1, EXP: 5/9/2014; DOCUSATE SODIUM, Capsule, 250 mg, NDC 00536375701, Pedigree: AD54498_4, EXP: 5/20/2014; guanFACINE HCl, Tablet, 1 mg, NDC 00591044401, Pedigree: AD39611_1, EXP: 4/30/2014.
Code information traZODone HCl, Tablet, 50 mg has the following codes Pedigree: AD37088_4, EXP: 5/9/2014; Pedigree: AD54562_1, EXP: 5/20/2014; Pedigree: AD39611_4, EXP: 5/14/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[1854]
FDA event record
· Exact recall-number query on openFDA
Recall number D-593-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 2,000 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; traZODone HCl Tablet, 50 mg may be potentially mislabeled as AMANTADINE HCL, Tablet, 100 mg, NDC 00832011100, Pedigree: AD54475_1, EXP: 5/20/2014.
Code information traZODone HCl, Tablet, 50 mg has the following code Pedigree: AD54475_7, EXP: 5/20/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[2768]
FDA event record
· Exact recall-number query on openFDA
Recall number D-594-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 300 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; traZODone HCl Tablet, 150 mg may be potentially mislabeled as NICOTINE POLACRILEX, Lozenge, 2 mg, NDC 00135051001, Pedigree: AD21858_1, EXP: 5/1/2014; SENNOSIDES, Tablet, 8.6 mg, NDC 00182109301, Pedigree: W003256, EXP: 6/17/2014.
Code information traZODone HCl, Tablet, 150 mg has the following codes Pedigree: AD21858_7, EXP: 5/1/2014; Pedigree: W003245, EXP: 6/17/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[4077]
FDA event record
· Exact recall-number query on openFDA
Recall number D-595-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 100 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; TORSEMIDE, Tablet, 10 mg may be potentially mislabeled as PYRIDOXINE HCL, Tablet, 50 mg, NDC 00536440801, Pedigree: AD30197_22, EXP: 5/9/2014.
Code information TORSEMIDE, Tablet, 10 mg has the following code Pedigree: AD30197_25, EXP: 5/9/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[1834]
FDA event record
· Exact recall-number query on openFDA
Recall number D-596-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 30 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; RIVAROXABAN Tablet, 20 mg may be potentially mislabeled as VENLAFAXINE HCL, Tablet, 100 mg, NDC 00093738301, Pedigree: W002619, EXP: 6/4/2014.
Code information RIVAROXABAN, Tablet, 20 mg has the following code Pedigree: W002620, EXP: 6/4/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[2766]
FDA event record
· Exact recall-number query on openFDA
Recall number D-597-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 100 Capsules
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; TACROLIMUS, Capsule, 1 mg may be potentially mislabeled as LEVOTHYROXINE SODIUM, Tablet, 125 mcg, NDC 00074706890, Pedigree: AD70633_4, EXP: 5/23/2014.
Code information TACROLIMUS, Capsule, 1 mg has the following code Pedigree: AD60590_1, EXP: 5/29/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[4114]
FDA event record
· Exact recall-number query on openFDA
Recall number D-598-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 30 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; SOLIFENACIN SUCCINATE Tablet, 5 mg may be potentially mislabeled as BROMOCRIPTINE MESYLATE, Tablet, 2.5 mg, NDC 00574010601, Pedigree: W003754, EXP: 6/26/2014.
Code information SOLIFENACIN SUCCINATE, Tablet, 5 mg has the following code Pedigree: W003755, EXP: 6/26/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[2747]
FDA event record
· Exact recall-number query on openFDA
Recall number D-599-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 600 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; PYRIDOXINE HCL Tablet, 50 mg may be potentially mislabeled as CALCIUM CITRATE, Tablet, 950 mg (200 mg Elem Ca), NDC 00904506260, Pedigree: W002699, EXP: 6/5/2014; MULTIVITAMIN/MULTIMINERAL W/IRON, Chew Tablet, NDC 00536781601, Pedigree: W003018, EXP: 6/12/2014; OMEGA-3 FATTY ACID, Capsule, 1000 mg, NDC 00904404360, Pedigree: W003705, EXP: 6/25/2014; LACTASE ENZYME, Tab
Code information PYRIDOXINE HCL, Tablet, 50 mg has the following codes Pedigree: W002697, EXP: 6/5/2014; Pedigree: W003019, EXP: 6/12/2014; Pedigree: W003718, EXP: 6/26/2014; Pedigree: AD46257_25, EXP: 5/15/2014; Pedigree: AD73521_25, EXP: 5/30/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[2767]
FDA event record
· Exact recall-number query on openFDA
Recall number D-600-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 450 Capsules
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; clomiPRAMINE HCl Capsule, 50 mg may be potentially mislabeled as guanFACINE HCl, Tablet, 1 mg, NDC 00378116001, Pedigree: AD46265_25, EXP: 5/15/2014; CHLORTHALIDONE, Tablet, 50 mg, NDC 00378021301, Pedigree: W002988, EXP: 6/11/2014; AMANTADINE HCL, Capsule, 100 mg, NDC 00781204801, Pedigree: W003674, EXP: 6/25/2014; ISOSORBIDE MONONITRATE, Tablet, 10 mg, NDC 6217501060
Code information clomiPRAMINE HCl, Capsule, 50 mg has the following codes Pedigree: AD46265_1, EXP: 5/15/2014; Pedigree: W002998, EXP: 6/11/2014; Pedigree: W003675, EXP: 6/25/2014; Pedigree: AD30140_4, EXP: 5/7/2014; Pedigree: AD73525_4, EXP: 5/30/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[3629]
FDA event record
· Exact recall-number query on openFDA
Recall number D-601-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 101 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; ETODOLAC, Tablet, 400 mg may be potentially mislabeled as PANCRELIPASE DR, Capsule, 12000 /38000 /60000 USP units, NDC 00032121201, Pedigree: W003731, EXP: 6/26/2014.
Code information ETODOLAC, Tablet, 400 mg has the following code Pedigree: W003734, EXP: 6/26/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[2833]
FDA event record
· Exact recall-number query on openFDA
Recall number D-602-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 200 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; WARFARIN SODIUM, Tablet, 0.5 mg (1/2 of 1 mg) may be potentially mislabeled as SODIUM CHLORIDE, Tablet, 1 mg, NDC 00223176001, Pedigree: AD70636_1, EXP: 5/29/2014.
Code information WARFARIN SODIUM, Tablet, 0.5 mg (1/2 of 1 mg) has the following code Pedigree: AD60590_4, EXP: 5/29/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[1248]
FDA event record
· Exact recall-number query on openFDA
Recall number D-603-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 200 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; WARFARIN SODIUM Tablet, 0.5 mg (1/2 of 1 mg) may be potentially mislabeled as SODIUM CHLORIDE, Tablet, 1 mg, NDC 00223176001, Pedigree: AD70636_1, EXP: 5/29/2014.
Code information WARFARIN SODIUM Tablet, 0.5 mg (1/2 of 1 mg) has the following code Pedigree: AD60590_4, EXP: 5/29/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[1865]
FDA event record
· Exact recall-number query on openFDA
Recall number D-604-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 200 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; carBAMazepine ER Tablet, 200 mg may be potentially mislabeled as ACARBOSE, Tablet, 25 mg, NDC 00054014025, Pedigree: AD60272_1, EXP: 5/22/2014.
Code information carBAMazepine ER, Tablet, 200 mg has the following code Pedigree: AD60272_7, EXP: 5/22/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[3648]
FDA event record
· Exact recall-number query on openFDA
Recall number D-605-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 718 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; MELATONIN Tablet, 3 mg may be potentially mislabeled as DOCUSATE SODIUM, Capsule, 250 mg, NDC 00536375701, Pedigree: AD25452_13, EXP: 5/3/2014; PIOGLITAZONE, Tablet, 15 mg, NDC 00591320530, Pedigree: AD28322_4, EXP: 4/30/2014; COENZYME Q-10, Capsule, 100 mg, NDC 37205055065, Pedigree: AD70655_11, EXP: 5/28/2014; COENZYME Q-10, Capsule, 100 mg, NDC 37205055065, Pedigree
Code information MELATONIN, Tablet, 3 mg has the following codes Pedigree: AD25452_16, EXP: 5/3/2014; Pedigree: AD28322_7, EXP: 5/6/2014; Pedigree: AD70655_14, EXP: 5/28/2014; Pedigree: W003999, EXP: 7/1/2014; Pedigree: AD32325_7, EXP: 5/9/2014; Pedigree: AD68019_7, EXP: 5/28/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[3633]
FDA event record
· Exact recall-number query on openFDA
Recall number D-606-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 1,399 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; PRENATAL MULTIVITAMIN/ MULTIMINERAL, Tablet may be potentially mislabeled as COLCHICINE, Tablet, 0.6 mg, NDC 64764011907, Pedigree: AD65457_1, EXP: 5/23/2014; GALANTAMINE HBr ER, Capsule, 8 mg, NDC 10147089103, Pedigree: W003509, EXP: 6/21/2014; BROMOCRIPTINE MESYLATE, Tablet, 2.5 mg, NDC 00781532531, Pedigree: AD32579_7, EXP: 5/9/2014; CINACALCET HCL, Tablet, 30 mg, N
Code information PRENATAL MULTIVITAMIN/ MULTIMINERAL, Tablet has the following codes Pedigree: AD62829_18, EXP: 5/24/2014; Pedigree: W003511, EXP: 6/21/2014; Pedigree: AD32579_4, EXP: 5/9/2014; Pedigree: AD73597_16, EXP: 5/31/2014; Pedigree: W003086, EXP: 6/12/2014; Pedigree: W003034, EXP: 6/12/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[2739]
FDA event record
· Exact recall-number query on openFDA
Recall number D-607-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 100 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; NEOMYCIN SULFATE, Tablet, 500 mg may be potentially mislabeled as IMIPRAMINE HCL, Tablet, 25 mg, NDC 00781176401, Pedigree: AD49448_10, EXP: 5/17/2014.
Code information NEOMYCIN SULFATE, Tablet, 500 mg has the following code Pedigree: AD49448_17, EXP: 5/17/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[4085]
FDA event record
· Exact recall-number query on openFDA
Recall number D-608-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 120 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; FIDAXOMICIN Tablet, 200 mg may be potentially mislabeled as BENAZEPRIL HCL, Tablet, 40 mg, NDC 65162075410, Pedigree: W003918, EXP: 6/28/2014.
Code information FIDAXOMICIN, Tablet, 200 mg has the following code Pedigree: W003920, EXP: 6/28/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[3943]
FDA event record
· Exact recall-number query on openFDA
Recall number D-609-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 100 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; HYDROcodone BITARTRATE/ ACETAMINOPHEN, Tablet, 7.5 mg/325 mg may be potentially mislabeled as MELATONIN, Tablet, 3 mg, NDC 51991001406, Pedigree: W003999, EXP: 7/1/2014.
Code information HYDROcodone BITARTRATE/ ACETAMINOPHEN, Tablet, 7.5 mg/325 mg has the following code Pedigree: W004005, EXP: 7/1/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[2820]
FDA event record
· Exact recall-number query on openFDA
Recall number D-610-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 100 Capsules
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; CHOLECALCIFEROL Capsule, 50000 units may be potentially mislabeled as FENOFIBRATE, Tablet, 54 mg, NDC 00378710077, Pedigree: AD60272_64, EXP: 5/22/2014.
Code information CHOLECALCIFEROL, Capsule, 50000 units has the following code Pedigree: AD60268_4, EXP: 5/22/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[2763]
FDA event record
· Exact recall-number query on openFDA
Recall number D-611-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 50 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; DOXYCYCLINE HYCLATE, Tablet, 100 mg may be potentially mislabeled as DESLORATADINE, Tablet, 5 mg, NDC 00085126401, Pedigree: AD30993_5, EXP: 2/28/2014.
Code information DOXYCYCLINE HYCLATE Tablet, 100 mg has the following code Pedigree: AD30993_8, EXP: 5/9/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[3571]
FDA event record
· Exact recall-number query on openFDA
Recall number D-612-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 300 Capsules
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; TRIMETHOBENZAMIDE HCl, Capsule, 300 mg may be potentially mislabeled as GABAPENTIN, Tablet, 600 mg, NDC 00228263611, Pedigree: AD21965_7, EXP: 5/1/2014; CHOLECALCIFEROL, Capsule, 5000 units, NDC 00904598660, Pedigree: AD70629_19, EXP: 5/29/2014; SODIUM BICARBONATE, Tablet, 650 mg, NDC 64980018210, Pedigree: W002970, EXP: 6/11/2014.
Code information TRIMETHOBENZAMIDE HCl, Capsule, 300 mg has the following codes Pedigree: AD21858_10, EXP: 5/1/2014; Pedigree: AD70625_1, EXP: 5/29/2014; Pedigree: W002976, EXP: 6/11/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[3590]
FDA event record
· Exact recall-number query on openFDA
Recall number D-613-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 240 Capsules
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; MESALAMINE CR, Capsule, 250 mg may be potentially mislabeled as ASPIRIN EC, Tablet, 325 mg, NDC 00904201360, Pedigree: AD52378_1, EXP: 5/17/2014.
Code information MESALAMINE CR, Capsule, 250 mg has the following code Pedigree: AD52412_1, EXP: 5/17/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[3436]
FDA event record
· Exact recall-number query on openFDA
Recall number D-614-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 111 Capsules
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; MESALAMINE CR, Capsule, 500 mg may be potentially mislabeled as clomiPRAMINE HCl, Capsule, 50 mg, NDC 51672401205, Pedigree: AD21790_7, EXP: 5/1/2014.
Code information MESALAMINE CR, Capsule, 500 mg has the following code Pedigree: AD21965_16, EXP: 5/1/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[2683]
FDA event record
· Exact recall-number query on openFDA
Recall number D-615-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 405 Chew Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; LANTHANUM CARBONATE Chew Tablet, 500 mg may be potentially mislabeled as ISONIAZID, Tablet, 300 mg, NDC 00555007102, Pedigree: AD32757_31, EXP: 5/13/2014; CYANOCOBALAMIN, Tablet, 1000 mcg, NDC 00536355601, Pedigree: AD32757_53, EXP: 5/14/2014; MAGNESIUM CHLORIDE, Tablet, 64 mg, NDC 68585000575, Pedigree: W002712, EXP: 6/6/2014; MAGNESIUM CHLORIDE, Tablet, 64 mg, NDC 68
Code information LANTHANUM CARBONATE, Chew Tablet, 500 mg has the following codes Pedigree: AD32764_5, EXP: 5/13/2014; Pedigree: AD32764_8, EXP: 5/14/2014; Pedigree: W002790, EXP: 6/6/2014; Pedigree: W003410, EXP: 6/19/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[3656]
FDA event record
· Exact recall-number query on openFDA
Recall number D-616-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 60 Capsules
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling:Label Mixup; GLUCOSAMINE/CHONDROITIN Capsule, 500 mg/400 mg may be potentially mislabeled as FEXOFENADINE HCL, Tablet, 60 mg, NDC 45802042578, Pedigree: AD60240_30, EXP: 5/22/2014.
Code information GLUCOSAMINE/CHONDROITIN, Capsule, 500 mg/400 mg has the following code Pedigree: AD60240_33, EXP: 5/22/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[4117]
FDA event record
· Exact recall-number query on openFDA
Recall number D-617-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 2,398 Capsules
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling:Label Mixup; VITAMIN B COMPLEX W/C Capsule may be potentially mislabeled as SODIUM CHLORIDE, Tablet, 1 mg, NDC 00223176001, Pedigree: AD39560_1, EXP: 5/13/2014.
Code information VITAMIN B COMPLEX W/C, Capsule has the following code Pedigree: AD39560_4, EXP: 5/13/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[3448]
FDA event record
· Exact recall-number query on openFDA
Recall number D-618-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 2,392 Capsules
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling:Label Mixup; LACTOBACILLUS ACIDOPHILUS Capsule may be potentially mislabeled as CHOLECALCIFEROL, Tablet, 2000 units, NDC 00904615760, Pedigree: AD65311_1, EXP: 5/24/2014; PANCRELIPASE DR, Capsule, 24000 /76000 /120000 USP units, NDC 00032122401, Pedigree: AD65457_4, EXP: 5/24/2014.
Code information LACTOBACILLUS ACIDOPHILUS, Capsule has the following codes Pedigree: AD65311_7, EXP: 5/24/2014; Pedigree: AD65311_4, EXP: 5/24/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[3635]
FDA event record
· Exact recall-number query on openFDA
Recall number D-619-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 210 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling:Label Mixup; OLANZapine, Tablet, 7.5 mg may be potentially mislabeled as LEVOTHYROXINE SODIUM, Tablet, 175 mcg, NDC 00527135001, Pedigree: AD46265_37, EXP: 5/15/2014; LEVOTHYROXINE SODIUM, Tablet, 88 mcg, NDC 00781518392, Pedigree: AD60272_73, EXP: 5/22/2014; MIRTAZAPINE, Tablet, 7.5 mg, NDC 59762141503, Pedigree: AD73525_55, EXP: 5/30/2014.
Code information OLANZapine, Tablet, 7.5 mg has the following codes Pedigree: AD46265_46, EXP: 5/15/2014; Pedigree: AD60272_79, EXP: 5/22/2014; Pedigree: AD73525_58, EXP: 5/30/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[1830]
FDA event record
· Exact recall-number query on openFDA
Recall number D-620-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 299 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling:Label Mixup; tiZANidine HCl Tablet, 1 mg (1/2 of 2 mg) may be potentially mislabeled as PYRIDOXINE HCL, Tablet, 50 mg, NDC 00536440801, Pedigree: AD60428_10, EXP: 5/22/2014.
Code information tiZANidine HCl, Tablet, 1 mg (1/2 of 2 mg) has the following code Pedigree: AD60272_52, EXP: 5/22/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[3483]
FDA event record
· Exact recall-number query on openFDA
Recall number D-621-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 600 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling:Label Mixup; tiZANidine HCl Tablet, 2 mg may be potentially mislabeled as RIBAVIRIN, Capsule, 200 mg, NDC 68382026007, Pedigree: AD21790_37, EXP: 4/30/2014; CYANOCOBALAMIN, Tablet, 1000 mcg, NDC 00904421713, Pedigree: AD46257_59, EXP: 5/15/2014; NIACIN, Tablet, 100 mg, NDC 00904227160, Pedigree: W002661, EXP: 6/5/2014; PANTOPRAZOLE SODIUM DR, Tablet, 20 mg, NDC 00008060601, Pedigree
Code information tiZANidine HCl, Tablet, 2 mg has the following codes Pedigree: AD21790_40, EXP: 5/1/2014; Pedigree: AD46265_16, EXP: 5/15/2014; Pedigree: W002663, EXP: 6/5/2014; Pedigree: AD73525_31, EXP: 5/30/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[3609]
FDA event record
· Exact recall-number query on openFDA
Recall number D-622-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 100 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling:Label Mixup; GLIMEPIRIDE, Tablet, 1 mg may be potentially mislabeled as clomiPRAMINE HCl, Capsule, 50 mg, NDC 51672401205, Pedigree: AD73525_4, EXP: 5/30/2014.
Code information GLIMEPIRIDE, Tablet, 1 mg has the following code Pedigree: AD73525_10, EXP: 5/30/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[3639]
FDA event record
· Exact recall-number query on openFDA
Recall number D-623-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 60 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling:Label Mixup; MODAFINIL Tablet, 50 mg (1/2 of 100 mg Tablet) may be potentially mislabeled as SACCHAROMYCES BOULARDII LYO, Capsule, 250 mg, NDC 00414200007, Pedigree: AD21859_1, EXP: 10/31/2013.
Code information MODAFINIL Tablet, 50 mg (1/2 of 100 mg Tablet) has the following code Pedigree: AD21787_4, EXP: 5/1/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[1576]
FDA event record
· Exact recall-number query on openFDA
Recall number D-624-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 600 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling:Label Mixup; CINACALCET HCL, Tablet, 30 mg may be potentially mislabeled as ACETAMINOPHEN, Chew Tablet, 80 mg, NDC 00536323307, Pedigree: W003113, EXP: 6/13/2014; FERROUS SULFATE, Tablet, 325 mg (65 mg Elemental Iron), NDC 00904759160, Pedigree: AD54553_1, EXP: 5/20/2014; OMEGA-3-ACID ETHYL ESTERS, Capsule, 1000 mg, NDC 00173078302, Pedigree: AD32757_40, EXP: 5/14/2014; COLCHICINE,
Code information CINACALCET HCL, Tablet, 30 mg has the following codes Pedigree: W003168, EXP: 6/13/2014; Pedigree: AD54516_4, EXP: 5/20/2014; Pedigree: AD32757_50, EXP: 5/14/2014; Pedigree: W003615, EXP: 6/25/2014; Pedigree: AD52778_82, EXP: 5/21/2014; Pedigree: AD73597_13, EXP: 5/31/2014; Pedigree: W003481, EXP: 6/20/2014; Pedigree: W003492, EXP: 6/20/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[3424]
FDA event record
· Exact recall-number query on openFDA
Recall number D-625-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 60 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling:Label Mixup; CINACALCET HCL Tablet, 60 mg may be potentially mislabeled as RANOLAZINE ER, Tablet, 500 mg, NDC 61958100301, Pedigree: W003741, EXP: 6/26/2014.
Code information CINACALCET HCL, Tablet, 60 mg has the following code Pedigree: W003742, EXP: 6/26/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[1245]
FDA event record
· Exact recall-number query on openFDA
Recall number D-626-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 200 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling:Label Mixup; traMADol HCl Tablet, 25 mg (1/2 of 50 mg) may be potentially mislabeled as LEVOTHYROXINE SODIUM, Tablet, 137 mcg, NDC 00527163801, Pedigree: AD60272_76, EXP: 5/22/2014.
Code information traMADol HCl, Tablet, 25 mg (1/2 of 50 mg) has the following code Pedigree: AD60272_92, EXP: 5/22/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[3645]
FDA event record
· Exact recall-number query on openFDA
Recall number D-627-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 299 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling:Label Mixup; tiZANidine HCL Tablet, 2 mg may be potentially mislabeled as NICOTINE POLACRILEX, Lozenge, 2 mg, NDC 37205098769, Pedigree: AD70700_4, EXP: 5/29/2014; NIFEdipine ER, Tablet, 60 mg, NDC 00591319401, Pedigree: W003729, EXP: 6/26/2014.
Code information tiZANidine HCL, Tablet, 2 mg has the following codes Pedigree: AD70700_10, EXP: 5/29/2014; Pedigree: W003750, EXP: 6/26/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[1814]
FDA event record
· Exact recall-number query on openFDA
Recall number D-628-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 402 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling:Label Mixup; METOPROLOL TARTRATE Tablet, 12.5 mg (1/2 of 25 mg) may be potentially mislabeled as DOCUSATE SODIUM, Capsule, 250 mg, NDC 00904789159, Pedigree: AD68022_1, EXP: 5/28/2014; METOPROLOL TARTRATE, Tablet, 12.5 mg (1/2 of 25 mg), NDC 57664050652, Pedigree: AD68010_14, EXP: 5/28/2014.
Code information METOPROLOL TARTRATE, Tablet, 12.5 mg (1/2 of 25 mg) has the following codes Pedigree: AD68010_14, EXP: 5/28/2014; Pedigree: AD68010_17, EXP: 5/28/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[2785]
FDA event record
· Exact recall-number query on openFDA
Recall number D-629-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 300 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling:Label Mixup; METOPROLOL TARTRATE, Tablet, 25 mg may be potentially mislabeled as ASCORBIC ACID, Tablet, 250 mg, NDC 00904052260, Pedigree: W003826, EXP: 6/27/2014; amLODIPine BESYLATE, Tablet, 5 mg, NDC 00093716798, Pedigree: W002840, EXP: 6/7/2014.
Code information METOPROLOL TARTRATE, Tablet, 25 mg has the following codes Pedigree: W003843, EXP: 6/27/2014; Pedigree: W002841, EXP: 6/7/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[1850]
FDA event record
· Exact recall-number query on openFDA
Recall number D-630-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 299 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling:Label Mixup; CITALOPRAM Tablet, 10 mg may be potentially mislabeled as OXYBUTYNIN CHLORIDE, Tablet, 5 mg, NDC 00603497521, Pedigree: AD52778_61, EXP: 5/20/2014; COENZYME Q-10, Capsule, 30 mg, NDC 00904501546, Pedigree: W002814, EXP: 6/7/2014.
Code information CITALOPRAM, Tablet, 10 mg has the following codes Pedigree: AD56921_1, EXP: 5/21/2014; Pedigree: W002844, EXP: 6/7/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[2800]
FDA event record
· Exact recall-number query on openFDA
Recall number D-631-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 100 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling:Label Mixup; ISOSORBIDE DINITRATE ER Tablet, 40 mg may be potentially mislabeled as CILOSTAZOL, Tablet, 50 mg, NDC 60505252101, Pedigree: AD21811_7, EXP: 5/1/2014.
Code information ISOSORBIDE DINITRATE ER, Tablet, 40 mg has the following code Pedigree: AD23082_4, EXP: 5/3/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[2784]
FDA event record
· Exact recall-number query on openFDA
Recall number D-632-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 200 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling:Label Mixup; PIMOZIDE Tablet, 1 mg (1/2 of 2 mg) may be potentially mislabeled as METOPROLOL TARTRATE, Tablet, 12.5 mg (1/2 of 25 mg), NDC 63304057901, Pedigree: AD73525_52, EXP: 5/30/2014.
Code information PIMOZIDE, Tablet, 1 mg (1/2 of 2 mg) has the following code Pedigree: AD73525_61, EXP: 5/30/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[4080]
FDA event record
· Exact recall-number query on openFDA
Recall number D-633-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 100 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling:Label Mixup; PIMOZIDE Tablet, 2 mg may be potentially mislabeled as DULoxetine HCl DR, Capsule, 20 mg, NDC 00002323560, Pedigree: AD30140_31, EXP: 5/7/2014.
Code information PIMOZIDE, Tablet, 2 mg has the following code Pedigree: AD30140_43, EXP: 5/7/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[4063]
FDA event record
· Exact recall-number query on openFDA
Recall number D-634-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 1,998 Capsules
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling:Label Mixup; DOCUSATE SODIUM Capsule, 100 mg may be potentially mislabeled as DOCUSATE SODIUM, Capsule, 250 mg, NDC 00536375701, Pedigree: AD37063_4, EXP: 5/13/2014; tiZANidine HCl, Tablet, 2 mg, NDC 00378072219, Pedigree: W002975, EXP: 6/11/2014.
Code information DOCUSATE SODIUM, Capsule, 100 mg has the following codes Pedigree: AD37063_1, EXP: 5/13/2014; Pedigree: W002977, EXP: 6/11/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[2810]
FDA event record
· Exact recall-number query on openFDA
Recall number D-635-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 100 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling:Label Mixup; CRANBERRY Tablet, 450 mg may be potentially mislabeled as METOPROLOL SUCCINATE ER, Tablet, 200 mg, NDC 62037083301, Pedigree: AD73652_13, EXP: 5/30/2014.
Code information CRANBERRY, Tablet, 450 mg has the following code Pedigree: AD73640_1, EXP: 5/30/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[2734]
FDA event record
· Exact recall-number query on openFDA
Recall number D-636-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 180 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling:Label Mixup; SEVELAMER HCl Tablet, 800 mg may be potentially mislabeled as RANOLAZINE ER, Tablet, 500 mg, NDC 61958100301, Pedigree: W002857, EXP: 6/7/2014.
Code information SEVELAMER HCl Tablet, 800 mg has the following code Pedigree: W002858, EXP: 6/7/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[3914]
FDA event record
· Exact recall-number query on openFDA
Recall number D-637-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 3,238 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling:Label Mixup; SEVELAMER CARBONATE Tablet, 800 mg may be potentially mislabeled as tiZANidine HCl, Tablet, 2 mg, NDC 55111017915, Pedigree: AD46265_16, EXP: 5/15/2014; LEVOTHYROXINE SODIUM, Tablet, 88 mcg, NDC 00781518392, Pedigree: AD70629_13, EXP: 5/29/2014; QUEtiapine FUMARATE, Tablet, 100 mg, NDC 60505313301, Pedigree: W002777, EXP: 6/6/2014; VALSARTAN, Tablet, 160 mg, NDC 0007803
Code information SEVELAMER CARBONATE, Tablet, 800 mg has the following codes Pedigree: AD39858_4, EXP: 5/15/2014; Pedigree: AD70629_16, EXP: 5/29/2014; Pedigree: W002778, EXP: 6/6/2014; Pedigree: W002859, EXP: 6/7/2014; Pedigree: W003029, EXP: 6/11/2014; Pedigree: AD56917_4, EXP: 5/21/2014; Pedigree: AD73627_11, EXP: 5/30/2014; Pedigree: W002710, EXP: 6/6/2014; Pedigree: W002623, EXP: 6/4/2014; Pedigree: W003491, EXP: 6/20/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[3427]
FDA event record
· Exact recall-number query on openFDA
Recall number D-638-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 180 Chew Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling:Label Mixup; MULTIVITAMIN/MULTIMINERAL Chew Tablet may be potentially mislabeled as LEVOTHYROXINE SODIUM, Tablet, 12.5 mcg (1/2 of 25 mcg), NDC 00527134101, Pedigree: AD30140_40, EXP: 5/7/2014; LACTOBACILLUS ACIDOPHILUS, Capsule, 500 Million CFU, NDC 43292050022, Pedigree: AD30028_10, EXP: 5/7/2014.
Code information MULTIVITAMIN/MULTIMINERAL, Chew Tablet has the following codes Pedigree: AD30180_10, EXP: 5/9/2014; Pedigree: AD32325_1, EXP: 5/9/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[2722]
FDA event record
· Exact recall-number query on openFDA
Recall number D-639-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 180 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling:Label Mixup; ARIPiprazole Tablet, 2 mg may be potentially mislabeled as tiZANidine HCl, Tablet, 2 mg, NDC 55111017915, Pedigree: AD21790_40, EXP: 5/1/2014; ATOMOXETINE HCL, Capsule, 80 mg, NDC 00002325030, Pedigree: AD30140_19, EXP: 5/7/2014; OLANZapine, Tablet, 7.5 mg, NDC 55111016530, Pedigree: AD46265_46, EXP: 5/15/2014; REPAGLINIDE, Tablet, 2 mg, NDC 00169008481, Pedigree: AD464
Code information ARIPiprazole, Tablet, 2 mg has the following codes Pedigree: AD21790_43, EXP: 5/1/2014; Pedigree: AD30140_25, EXP: 5/7/2014; Pedigree: AD46265_19, EXP: 5/15/2014; Pedigree: AD46414_1, EXP: 5/16/2014; Pedigree: W003004, EXP: 6/11/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[1619]
FDA event record
· Exact recall-number query on openFDA
Recall number D-640-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 150 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling:Label Mixup; ARIPiprazole, Tablet, 15 mg may be potentially mislabeled as ATOMOXETINE HCL, Capsule, 40 mg, NDC 00002322930, Pedigree: AD21790_82, EXP: 5/1/2014; PRAMIPEXOLE DI-HCL, Tablet, 0.125 mg, NDC 13668009190, Pedigree: AD25264_10, EXP: 5/3/2014.
Code information ARIPiprazole Tablet, 15 mg has the following codes Pedigree: AD21965_1, EXP: 5/1/2014; Pedigree: AD28322_1, EXP: 5/6/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[2675]
FDA event record
· Exact recall-number query on openFDA
Recall number D-641-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 90 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling:Label Mixup; DARUNAVIR Tablet, 800 mg may be potentially mislabeled as HYDROcodone BITARTRATE/ ACETAMINOPHEN, Tablet, 7.5 mg/325 mg, NDC 52544016201, Pedigree: W004005, EXP: 7/1/2014.
Code information DARUNAVIR, Tablet, 800 mg has the following code Pedigree: W003929, EXP: 7/1/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[1629]
FDA event record
· Exact recall-number query on openFDA
Recall number D-642-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 21 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling:Label Mixup; methylPREDNISolone Tablet, 4 mg may be potentially mislabeled as LEVOTHYROXINE SODIUM, Tablet, 137 mcg, NDC 00781519192, Pedigree: AD22616_10, EXP: 5/2/2014.
Code information methylPREDNISolone, Tablet, 4 mg has the following code Pedigree: AD21811_17, EXP: 5/1/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[3476]
FDA event record
· Exact recall-number query on openFDA
Recall number D-643-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 120 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling:Label Mixup; COLESTIPOL HCL MICRONIZED Tablet, 1 g may be potentially mislabeled as rifAXIMin, Tablet, 200 mg, NDC 65649030103, Pedigree: AD54587_10, EXP: 4/30/2014.
Code information COLESTIPOL HCL MICRONIZED, Tablet, 1 g has the following code Pedigree: AD56847_1, EXP: 5/21/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[3486]
FDA event record
· Exact recall-number query on openFDA
Recall number D-644-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 100 Capsules
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling:Label Mixup; NIFEdipine, Capsule, 10 mg may be potentially mislabeled as NITROFURANTOIN MONOHYDRATE/ MACROCRYSTALS, Capsule, 100 mg, NDC 47781030301, Pedigree: AD52778_58, EXP: 5/20/2014.
Code information NIFEdipine, Capsule, 10 mg has the following code Pedigree: AD52778_55, EXP: 5/20/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[4119]
FDA event record
· Exact recall-number query on openFDA
Recall number D-645-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 91 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling:Label Mixup; MIRTAZAPINE Tablet, 7.5 mg may be potentially mislabeled as BROMOCRIPTINE MESYLATE, Tablet, 2.5 mg, NDC 00574010603, Pedigree: AD73525_40, EXP: 5/30/2014; DULoxetine HCl DR, Capsule, 20 mg, NDC 00002323560, Pedigree: W003005, EXP: 6/11/2014; carBAMazepine ER, Tablet, 100 mg, NDC 00078051005, Pedigree: W003330, EXP: 6/18/2014.
Code information MIRTAZAPINE, Tablet, 7.5 mg has the following codes Pedigree: AD73525_55, EXP: 5/30/2014; Pedigree: W003012, EXP: 6/11/2014; Pedigree: W003334, EXP: 6/18/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[3897]
FDA event record
· Exact recall-number query on openFDA
Recall number D-646-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 90 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling:Label Mixup; MIRTAZAPINE Tablet, 7.5 mg may be potentially mislabeled as ISONIAZID, Tablet, 300 mg, NDC 00555007102, Pedigree: W003691, EXP: 6/26/2014.
Code information MIRTAZAPINE, Tablet, 7.5 mg has the following code Pedigree: W003693, EXP: 4/30/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[3607]
FDA event record
· Exact recall-number query on openFDA
Recall number D-647-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 100 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling:Label Mixup; medroxyPROGESTERone ACETATE, Tablet, 10 mg may be potentially mislabeled as hydrALAZINE HCl, Tablet, 100 mg, NDC 23155000401, Pedigree: AD46312_13, EXP: 5/16/2014.
Code information medroxyPROGESTERone ACETATE, Tablet, 10 mg has the following code Pedigree: AD46312_19, EXP: 5/16/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[3692]
FDA event record
· Exact recall-number query on openFDA
Recall number D-648-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 100 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling:Label Mixup; sulfaSALAzine Tablet, 500 mg may be potentially mislabeled as HYOSCYAMINE SULFATE SL, Tablet, 0.125 mg, NDC 00574025001, Pedigree: AD46265_7, EXP: 5/15/2014.
Code information sulfaSALAzine, Tablet, 500 mg has the following code Pedigree: AD46265_13, EXP: 5/15/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[1564]
FDA event record
· Exact recall-number query on openFDA
Recall number D-649-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 120 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling:Label Mixup; MISOPROSTOL Tablet, 200 mcg may be potentially mislabeled as PROPRANOLOL HCL, Tablet, 10 mg, NDC 23155011001, Pedigree: AD21790_34, EXP: 5/1/2014; SODIUM CHLORIDE, Tablet, 1 mg, NDC 00223176001, Pedigree: W003115, EXP: 6/13/2014.
Code information MISOPROSTOL, Tablet, 200 mcg has the following codes Pedigree: AD21965_13, EXP: 5/1/2014; Pedigree: W003117, EXP: 6/13/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[3584]
FDA event record
· Exact recall-number query on openFDA
Recall number D-650-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 90 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling:Label Mixup; QUINAPRIL HCL Tablet, 10 mg may be potentially mislabeled as PROPRANOLOL HCL, Tablet, 80 mg, NDC 23155011401, Pedigree: AD42566_4, EXP: 5/14/2014.
Code information QUINAPRIL HCL, Tablet, 10 mg has the following code Pedigree: AD42611_4, EXP: 5/14/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[3606]
FDA event record
· Exact recall-number query on openFDA
Recall number D-651-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 200 Capsules
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling:Label Mixup; ZINC SULFATE Capsule, 220 mg may be potentially mislabeled as CALCIUM ACETATE, Capsule, 667 mg, NDC 00054008826, Pedigree: AD52778_10, EXP: 5/20/2014; CALCITRIOL, Capsule, 0.25 mcg, NDC 00054000725, Pedigree: W003638, EXP: 6/25/2014.
Code information ZINC SULFATE, Capsule, 220 mg has the following codes Pedigree: AD52993_34, EXP: 5/20/2014; Pedigree: W003641, EXP: 6/25/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[2860]
FDA event record
· Exact recall-number query on openFDA
Recall number D-652-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 300 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling:Label Mixup; ASCORBIC ACID Tablet, 500 mg may be potentially mislabeled as FEBUXOSTAT, Tablet, 40 mg, NDC 64764091830, Pedigree: AD23082_16, EXP: 11/1/2013.
Code information ASCORBIC ACID Tablet, 500 mg has the following code Pedigree: AD23082_19, EXP: 5/6/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[2788]
FDA event record
· Exact recall-number query on openFDA
Recall number D-653-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 600 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling:Label Mixup; VITAMIN B COMPLEX WITH C/FOLIC ACID, Tablet may be potentially mislabeled as LEVOTHYROXINE SODIUM, Tablet, 88 mcg, NDC 00378180701, Pedigree: AD73652_10, EXP: 5/30/2014; HYOSCYAMINE SULFATE ER, Tablet, 0.375 mg, NDC 43199001401, Pedigree: W003576, EXP: 6/24/2014; MELATONIN, Tablet, 3 mg, NDC 51991001406, Pedigree: AD70655_14, EXP: 5/28/2014; MELATONIN, Tablet, 3 mg, NDC
Code information VITAMIN B COMPLEX WITH C/FOLIC ACID, Tablet has the following codes Pedigree: AD73652_19, EXP: 5/30/2014; Pedigree: W003591, EXP: 6/24/2014; Pedigree: AD70655_17, EXP: 5/28/2014; Pedigree: W003361, EXP: 6/19/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[3953]
FDA event record
· Exact recall-number query on openFDA
Recall number D-654-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 100 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling:Label Mixup; MAGNESIUM GLUCONATE DIHYDRATE Tablet, 500 mg (27 mg Elemental Magnesium) may be potentially mislabeled as hydrALAZINE HCl, Tablet, 100 mg, NDC 23155000401, Pedigree: AD30197_7, EXP: 5/9/2014.
Code information MAGNESIUM GLUCONATE DIHYDRATE, Tablet, 500 mg (27 mg Elemental Magnesium) has the following code Pedigree: AD30197_16, EXP: 5/9/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[2836]
FDA event record
· Exact recall-number query on openFDA
Recall number D-655-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 203 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling:Label Mixup; CYPROHEPTADINE HCL Tablet, 4 mg may be potentially mislabeled as ACARBOSE, Tablet, 25 mg, NDC 00054014025, Pedigree: W003673, EXP: 6/25/2014; AMANTADINE HCL, Capsule, 100 mg, NDC 00781204801, Pedigree: W003323, EXP: 6/18/2014.
Code information CYPROHEPTADINE HCL, Tablet, 4 mg has the following codes Pedigree: W003676, EXP: 6/25/2014; Pedigree: W003324, EXP: 6/18/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[3447]
FDA event record
· Exact recall-number query on openFDA
Recall number D-656-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 300 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling:Label Mixup; SENNOSIDES Tablet, 8.6 mg may be potentially mislabeled as SACCHAROMYCES BOULARDII LYO, Capsule, 250 mg, NDC 00414200007, Pedigree: AD37063_7, EXP: 5/13/2014.
Code information SENNOSIDES, Tablet, 8.6 mg has the following code Pedigree: AD37063_17, EXP: 5/13/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[3909]
FDA event record
· Exact recall-number query on openFDA
Recall number D-657-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 90 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling:Label Mixup; FOSINOPRIL SODIUM Tablet, 10 mg may be potentially mislabeled as CALCITRIOL, Capsule, 0.25 mcg, NDC 00054000725, Pedigree: AD46414_10, EXP: 5/16/2014.
Code information FOSINOPRIL SODIUM, Tablet, 10 mg has the following code Pedigree: AD46414_19, EXP: 5/16/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[2807]
FDA event record
· Exact recall-number query on openFDA
Recall number D-658-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 90 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling:Label Mixup; FOSINOPRIL SODIUM, Tablet, 20 mg may be potentially mislabeled as TOLTERODINE TARTRATE ER, Capsule, 2 mg, NDC 00009519001, Pedigree: AD65478_1, EXP: 5/29/2014.
Code information FOSINOPRIL SODIUM, Tablet, 20 mg has the following code Pedigree: AD70690_1, EXP: 5/29/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[3446]
FDA event record
· Exact recall-number query on openFDA
Recall number D-659-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 60 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling:Label Mixup; CILOSTAZOL Tablet, 100 mg may be potentially mislabeled as DUTASTERIDE, Capsule, 0.5 mg, NDC 00173071204, Pedigree: AD65475_1, EXP: 5/28/2014.
Code information CILOSTAZOL, Tablet, 100 mg has the following code Pedigree: AD65475_4, EXP: 5/28/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[1811]
FDA event record
· Exact recall-number query on openFDA
Recall number D-660-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 60 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling:Label Mixup; CILOSTAZOL Tablet, 100 mg may be potentially mislabeled as DUTASTERIDE, Capsule, 0.5 mg, NDC 00173071204, Pedigree: AD65475_1, EXP: 5/28/2014.
Code information CILOSTAZOL Tablet, 100 mg has the following code Pedigree: AD65475_4, EXP: 5/28/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[2790]
FDA event record
· Exact recall-number query on openFDA
Recall number D-661-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 90 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling:Label Mixup; ATORVASTATIN CALCIUM Tablet, 20 mg may be potentially mislabeled as guaiFENesin ER, Tablet, 600 mg, NDC 63824000834, Pedigree: W003850, EXP: 6/27/2014.
Code information ATORVASTATIN CALCIUM, Tablet, 20 mg has the following code Pedigree: W003846, EXP: 6/27/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[3485]
FDA event record
· Exact recall-number query on openFDA
Recall number D-662-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 90 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling:Label Mixup; ATORVASTATIN CALCIUM, Tablet, 80 mg may be potentially mislabeled as LACTOBACILLUS GG, Capsule, 10 Billion Cells, NDC 49100036374, Pedigree: AD21965_19, EXP: 5/1/2014.
Code information ATORVASTATIN CALCIUM, Tablet, 80 mg has the following code Pedigree: AD21965_4, EXP: 5/1/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[3903]
FDA event record
· Exact recall-number query on openFDA
Recall number D-663-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 60 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling:Label Mixup; OLANZAPINE, Tablet 7.5 mg may be potentially mislabeled as NORTRIPTYLINE HCL, Capsule, 75 mg, NDC 00093081301, Pedigree: AD21790_73, EXP: 5/1/2014.
Code information OLANZAPINE, Tablet, 7.5 mg has the following code Pedigree: AD21790_76, EXP: 5/1/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[4103]
FDA event record
· Exact recall-number query on openFDA
Recall number D-664-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 400 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling:Label Mixup; QUEtiapine FUMARATE, Tablet, 25 mg may be potentially mislabeled as MULTIVITAMIN/MULTIMINERAL, Chew Tablet, NDC 58914001460, Pedigree: AD32325_1, EXP: 5/9/2014; ASPIRIN DR EC, Tablet, 81 mg, NDC 00182106105, Pedigree: W003094, EXP: 6/13/2014.
Code information QUEtiapine FUMARATE, Tablet, 25 mg has the following codes Pedigree: AD33897_25, EXP: 5/9/2014; Pedigree: W003099, EXP: 6/13/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[3900]
FDA event record
· Exact recall-number query on openFDA
Recall number D-665-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 1,300 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling:Label Mixup; QUEtiapine FUMARATE Tablet, 100 mg may be potentially mislabeled as DOCUSATE CALCIUM, Capsule, 240 mg, NDC 00536375501, Pedigree: W002776, EXP: 6/6/2014; NICOTINE POLACRILEX, Lozenge, 2 mg, NDC 37205098769, Pedigree: W003823, EXP: 6/27/2014; DOCUSATE SODIUM, Capsule, 250 mg, NDC 00536375710, Pedigree: AD60578_5, EXP: 5/29/2014.
Code information QUEtiapine FUMARATE, Tablet, 100 mg has the following codes Pedigree: W002777, EXP: 6/6/2014; Pedigree: W003825, EXP: 6/27/2014; Pedigree: AD73623_13, EXP: 5/30/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[3597]
FDA event record
· Exact recall-number query on openFDA
Recall number D-666-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 100 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling:Label Mixup; ESTERIFIED ESTROGENS, Tablet, 0.625 mg may be potentially mislabeled as ETODOLAC, Tablet, 400 mg, NDC 51672401801, Pedigree: W003734, EXP: 6/26/2014.
Code information ESTERIFIED ESTROGENS, Tablet, 0.625 mg has the following code Pedigree: W003736, EXP: 6/26/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[1862]
FDA event record
· Exact recall-number query on openFDA
Recall number D-667-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 840 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling:Label Mixup; RANOLAZINE ER Tablet, 500 mg may be potentially mislabeled as MELATONIN, Tablet, 3 mg, NDC 51991001406, Pedigree: AD25452_16, EXP: 5/3/2014; DULoxetine HCl DR, Capsule, 20 mg, NDC 00002323560, Pedigree: AD70585_16, EXP: 5/29/2014; OMEGA-3 FATTY ACID, Capsule, 1000 mg, NDC 00904404360, Pedigree: W002852, EXP: 6/7/2014; VALSARTAN, Tablet, 80 mg, NDC 00078035834, Pedigree:
Code information RANOLAZINE ER, Tablet, 500 mg has the following codes Pedigree: AD23087_1, EXP: 5/2/2014; Pedigree: AD62995_7, EXP: 5/29/2014; Pedigree: W002857, EXP: 6/7/2014; Pedigree: W003538, EXP: 6/21/2014; Pedigree: W003741, EXP: 6/26/2014; Pedigree: AD32757_47, EXP: 5/13/2014; Pedigree: W003648, EXP: 6/25/2014; Pedigree: AD60272_40, EXP: 5/22/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[1826]
FDA event record
· Exact recall-number query on openFDA
Recall number D-668-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 100 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling:Label Mixup; METOPROLOL SUCCINATE ER, Tablet, 200 mg may be potentially mislabeled as Pedigree: AD73652_13, EXP: 5/30/2014.
Code information METOPROLOL SUCCINATE ER Tablet, 200 mg
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[3881]
FDA event record
· Exact recall-number query on openFDA
Recall number D-669-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 100 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling:Label Mixup; ISOSORBIDE MONONITRATE Tablet, 10 mg may be potentially mislabeled as ASCORBIC ACID, Tablet, 250 mg, NDC 00904052260, Pedigree: AD28322_10, EXP: 5/6/2014.
Code information ISOSORBIDE MONONITRATE Tablet, 10 mg has the following code Pedigree: AD28352_1, EXP: 5/7/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[3621]
FDA event record
· Exact recall-number query on openFDA
Recall number D-670-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 300 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling:Label Mixup; ISOSORBIDE MONONITRATE Tablet, 20 mg may be potentially mislabeled as COLCHICINE, Tablet, 0.6 mg, NDC 64764011907, Pedigree: AD52778_22, EXP: 5/20/2014; LOSARTAN POTASSIUM, Tablet, 25 mg, NDC 16714058102, Pedigree: AD67989_7, EXP: 5/28/2014; SODIUM CHLORIDE, Tablet, 1 mg, NDC 00223176001, Pedigree: W002611, EXP: 6/4/2014.
Code information ISOSORBIDE MONONITRATE, Tablet, 20 mg has the following codes Pedigree: AD52778_31, EXP: 5/20/2014; Pedigree: AD67989_10, EXP: 5/28/2014; Pedigree: W002656, EXP: 6/4/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[3575]
FDA event record
· Exact recall-number query on openFDA
Recall number D-671-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 700 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling:Label Mixup; ISOSORBIDE MONONITRATE ER Tablet, 30 mg may be potentially mislabeled as LOSARTAN POTASSIUM, Tablet, 25 mg, NDC 16714058102, Pedigree: W003899, EXP: 6/27/2014; MISOPROSTOL, Tablet, 100 mcg, NDC 43386016012, Pedigree: AD42611_7, EXP: 5/14/2014; hydrOXYzine PAMOATE, Capsule, 100 mg, NDC 00555032402, Pedigree: W003332, EXP: 6/18/2014; glyBURIDE, Tablet, 2.5 mg, NDC 0009383
Code information ISOSORBIDE MONONITRATE ER Tablet, 30 mg has the following codes Pedigree: W003996, EXP: 7/1/2014; Pedigree: AD46297_1, EXP: 5/15/2014; Pedigree: W003350, EXP: 6/18/2014; Pedigree: AD21790_64, EXP: 5/1/2014; Pedigree: AD32757_37, EXP: 5/14/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[1602]
FDA event record
· Exact recall-number query on openFDA
Recall number D-672-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 90 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling:Label Mixup; PANTOPRAZOLE SODIUM DR, Tablet, 20 mg may be potentially mislabeled as DRONEDARONE HCL, Tablet, 400 mg, NDC 00024414260, Pedigree: AD52778_52, EXP: 5/20/2014.
Code information PANTOPRAZOLE SODIUM DR Tablet, 20 mg has the following code Pedigree: AD52778_64, EXP: 5/20/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[1816]
FDA event record
· Exact recall-number query on openFDA
Recall number D-673-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 100 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling:Label Mixup; OXcarbazepine Tablet, 150 mg may be potentially mislabeled as traZODone HCl, Tablet, 50 mg, NDC 50111043301, Pedigree: AD54562_1, EXP: 5/20/2014.
Code information OXcarbazepine, Tablet, 150 mg has the following code Pedigree: AD54562_4, EXP: 5/20/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[4096]
FDA event record
· Exact recall-number query on openFDA
Recall number D-674-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 100 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling:Label Mixup; OXcarbazepine Tablet, 600 mg may be potentially mislabeled as LACTASE ENZYME, Tablet, 3000 units, NDC 24385014976, Pedigree: AD30028_25, EXP: 5/7/2014.
Code information OXcarbazepine, Tablet, 600 mg has the following code Pedigree: AD30140_46, EXP: 5/7/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[1609]
FDA event record
· Exact recall-number query on openFDA
Recall number D-675-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 30 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling:Label Mixup; LETROZOLE Tablet, 2.5 mg may be potentially mislabeled as METOPROLOL TARTRATE, Tablet, 50 mg, NDC 00093073301, Pedigree: W003848, EXP: 6/27/2014.
Code information LETROZOLE, Tablet, 2.5 mg has the following code Pedigree: W003868, EXP: 6/27/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[2742]
FDA event record
· Exact recall-number query on openFDA
Recall number D-676-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 500 Capsules
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling:Label Mixup; CALCITRIOL, Capsule, 0.5 mcg may be potentially mislabeled as NIACIN TR, Tablet, 250 mg, NDC 10939043533, Pedigree: W003756, EXP: 5/31/2014; ISONIAZID, Tablet, 300 mg, NDC 00555007102, Pedigree: AD32757_28, EXP: 5/13/2014.
Code information CALCITRIOL, Capsule, 0.5 mcg has the following codes Pedigree: W003730, EXP: 6/26/2014; Pedigree: AD32757_10, EXP: 5/14/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[2816]
FDA event record
· Exact recall-number query on openFDA
Recall number D-677-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 200 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling:Label Mixup; HYDROXYCHLOROQUINE SULFATE, Tablet, 200 mg may be potentially mislabeled as guanFACINE HCl, Tablet, 1 mg, NDC 00378116001, Pedigree: AD70629_7, EXP: 5/29/2014.
Code information HYDROXYCHLOROQUINE SULFATE, Tablet, 200 mg has the following code Pedigree: AD70629_10, EXP: 5/29/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[3641]
FDA event record
· Exact recall-number query on openFDA
Recall number D-678-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 420 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling:Label Mixup; METOPROLOL TARTRATE, Tablet, 12.5 mg (1/2 of 25 mg) may be potentially mislabeled as PIOGLITAZONE, Tablet, 15 mg, NDC 00591320530, Pedigree: AD22845_1, EXP: 4/30/2014; LEVOTHYROXINE SODIUM, Tablet, 12.5 mcg (1/2 of 25 mcg), NDC 00527134101, Pedigree: AD73525_49, EXP: 5/30/2014.
Code information METOPROLOL TARTRATE, Tablet, 12.5 mg (1/2 of 25 mg) has the following codes Pedigree: AD21790_67, EXP: 5/1/2014; Pedigree: AD73525_52, EXP: 5/30/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[2822]
FDA event record
· Exact recall-number query on openFDA
Recall number D-679-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 398 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling:Label Mixup; ATENOLOL, Tablet, 12.5 mg (1/2 of 25 mg) may be potentially mislabeled as VITAMIN B COMPLEX WITH C/FOLIC ACID, Tablet, NDC 60258016001, Pedigree: AD73652_19, EXP: 5/30/2014; PIROXICAM, Capsule, 10 mg, NDC 00093075601, Pedigree: AD21836_1, EXP: 3/31/2014.
Code information ATENOLOL, Tablet, 12.5 mg (1/2 of 25 mg) has the following codes Pedigree: AD73525_1, EXP: 5/30/2014; Pedigree: AD30140_1, EXP: 5/7/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[1808]
FDA event record
· Exact recall-number query on openFDA
Recall number D-680-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 100 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling:Label Mixup; ESZOPICLONE, Tablet, 3 mg may be potentially mislabeled as CHOLECALCIFEROL, Tablet, 1000 units, NDC 00904582460, Pedigree: W002779, EXP: 6/6/2014.
Code information ESZOPICLONE, Tablet, 3 mg has the following code Pedigree: W002765, EXP: 6/6/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[1819]
FDA event record
· Exact recall-number query on openFDA
Recall number D-681-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 60 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling:Label Mixup; LURASIDONE HCl Tablet, 120 mg may be potentially mislabeled as DULoxetine HCl DR, Capsule, 20 mg, NDC 00002323560, Pedigree: W003486, EXP: 6/20/2014.
Code information LURASIDONE HCL, Tablet, 120 mg has the following code Pedigree: W003487, EXP: 6/20/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[3562]
FDA event record
· Exact recall-number query on openFDA
Recall number D-682-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 600 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling:Label Mixup; guaiFENesin ER, Tablet, 600 mg may be potentially mislabeled as MISOPROSTOL, Tablet, 200 mcg, NDC 59762500801, Pedigree: AD21965_13, EXP: 5/1/2014; TACROLIMUS, Capsule, 1 mg, NDC 00781210301, Pedigree: AD56917_7, EXP: 5/21/2014; LACTOBACILLUS GG, Capsule, NDC 49100036374, Pedigree: AD73627_17, EXP: 5/30/2014; LACTOBACILLUS GG, Capsule, NDC 49100036374, Pedigree: W003216
Code information guaiFENesin ER, Tablet, 600 mg has the following codes Pedigree: AD21965_22, EXP: 5/1/2014; Pedigree: AD56917_13, EXP: 5/21/2014; Pedigree: AD73627_23, EXP: 5/30/2014; Pedigree: W003218, EXP: 6/17/2014; Pedigree: W003360, EXP: 6/19/2014; Pedigree: W002660, EXP: 6/5/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[1869]
FDA event record
· Exact recall-number query on openFDA
Recall number D-683-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 480 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling:Label Mixup; guaiFENesin ER, Tablet, 600 mg may be potentially mislabeled as PRENATAL MULTIVITAMIN/ MULTIMINERAL, Tablet, NDC 51991056601, Pedigree: AD62829_18, EXP: 5/24/2014; guaiFENesin ER, Tablet, 600 mg, NDC 63824000834, Pedigree: AD62834_4, EXP: 5/24/2014; diphenhydrAMINE HCl, Tablet, 25 mg, NDC 00904555159, Pedigree: W003513, EXP: 6/21/2014; DOCUSATE SODIUM, Capsule, 250 mg,
Code information guaiFENesin ER, Tablet, 600 mg has the following codes Pedigree: AD62834_4, EXP: 5/24/2014; Pedigree: AD62834_7, EXP: 5/24/2014; Pedigree: W003514, EXP: 6/21/2014; Pedigree: W003574, EXP: 6/24/2014; Pedigree: W003850, EXP: 6/27/2014; Pedigree: W003931, EXP: 6/28/2014; Pedigree: AD46429_1, EXP: 5/15/2014; Pedigree: AD73592_1, EXP: 5/31/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[3482]
FDA event record
· Exact recall-number query on openFDA
Recall number D-684-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 500 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling:Label Mixup; guaiFENesin ER Tablet, 600 mg may be potentially mislabeled as OMEGA-3-ACID ETHYL ESTERS, Capsule, 1000 mg, NDC 00173078302, Pedigree: W003243, EXP: 6/17/2014.
Code information guaiFENesin ER, Tablet, 600 mg has the following code Pedigree: W003244, EXP: 6/17/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[3602]
FDA event record
· Exact recall-number query on openFDA
Recall number D-685-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 80 Lozenges
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling:Label Mixup; BENZOCAINE/MENTHOL Lozenge, 15 mg/3.6 mg may be potentially mislabeled as LUBIPROSTONE, Capsule, 24 mcg, NDC 64764024060, Pedigree: AD21811_1, EXP: 5/1/2014; LOSARTAN POTASSIUM, Tablet, 50 mg, NDC 00093736598, Pedigree: W003268, EXP: 6/17/2014.
Code information BENZOCAINE/MENTHOL, Lozenge, 15 mg/3.6 mg has the following codes Pedigree: AD21811_4, EXP: 5/1/2014; Pedigree: W003273, EXP: 6/17/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[1838]
FDA event record
· Exact recall-number query on openFDA
Recall number D-686-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 32 Lozenges
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling:Label Mixup; BENZOCAINE/MENTHOL Lozenge, 15 mg/2.6 mg may be potentially mislabeled as CHOLECALCIFEROL/ CALCIUM/ PHOSPHORUS, Tablet, 120 units/105 mg/81 mg, NDC 64980015001, Pedigree: AD32345_1, EXP: 5/14/2014.
Code information BENZOCAINE/MENTHOL, Lozenge, 15 mg/2.6 mg has the following code Pedigree: AD42592_4, EXP: 5/14/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[1626]
FDA event record
· Exact recall-number query on openFDA
Recall number D-687-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 100 Chew Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling:Label Mixup; MULTIVITAMIN/MULTIMINERAL W/FLUORIDE, Chew Tablet, 1 mg (F) may be potentially mislabeled as ISOMETHEPTENE MUCATE/ DICHLORALPHENAZONE/APAP, Capsule, 65 mg/100 mg/325 mg, NDC 44183044001, Pedigree: AD22858_1, EXP: 3/31/2014.
Code information MULTIVITAMIN/MULTIMINERAL W/FLUORIDE, Chew Tablet, 1 mg (F) has the following code Pedigree: AD22609_7, EXP: 5/2/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[2771]
FDA event record
· Exact recall-number query on openFDA
Recall number D-688-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 400 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling:Label Mixup; MULTIVITAMIN/MULTIMINERAL LOW IRON Tablet may be potentially mislabeled as LEVOTHYROXINE SODIUM, Tablet, 112 mcg, NDC 00527134601, Pedigree: AD60272_22, EXP: 5/22/2014; ATORVASTATIN CALCIUM, Tablet, 80 mg, NDC 00378212277, Pedigree: AD73627_1, EXP: 5/30/2014; MULTIVITAMIN/MULTIMINERAL, Tablet, NDC 37205018581, Pedigree: W002513, EXP: 6/3/2014.
Code information MULTIVITAMIN/MULTIMINERAL LOW IRON Tablet has the following codes Pedigree: AD60272_31, EXP: 5/22/2014; Pedigree: AD73627_8, EXP: 5/30/2014; Pedigree: W002507, EXP: 6/3/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[3659]
FDA event record
· Exact recall-number query on openFDA
Recall number D-689-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 90 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling:Label Mixup; PANTOPRAZOLE SODIUM DR Tablet, 20 mg may be potentially mislabeled as FOSINOPRIL SODIUM, Tablet, 20 mg, NDC 60505251102, Pedigree: AD70690_1, EXP: 5/29/2014.
Code information PANTOPRAZOLE SODIUM DR Tablet, 20 mg has the following codes Pedigree: AD70690_4, EXP: 5/29/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[4121]
FDA event record
· Exact recall-number query on openFDA
Recall number D-690-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 1,001 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling:Label Mixup; PANTOPRAZOLE SODIUM DR Tablet, 40 mg may be potentially mislabeled as SENNOSIDES, Tablet, 8.6 mg, NDC 60258095001, Pedigree: AD37063_17, EXP: 5/13/2014.
Code information PANTOPRAZOLE SODIUM DR Tablet, 40 mg has the following code Pedigree: AD37063_10, EXP: 5/13/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[3595]
FDA event record
· Exact recall-number query on openFDA
Recall number D-691-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 402 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; ZOLPIDEM TARTRATE Tablet, 2.5 mg (1/2 of 5 mg) may be potentially mislabeled as TEMAZEPAM, Capsule, 7.5 mg, NDC 00378311001, Pedigree: AD22861_7, EXP: 5/8/2014.
Code information ZOLPIDEM TARTRATE Tablet, 2.5 mg (1/2 of 5 mg) has the following code Pedigree: AD28355_1, EXP: 5/8/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[1812]
FDA event record
· Exact recall-number query on openFDA
Recall number D-692-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 300 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; LISINOPRIL Tablet, 2.5 mg may be potentially mislabeled as RANOLAZINE ER, Tablet, 500 mg, NDC 61958100301, Pedigree: AD23087_1, EXP: 5/2/2014; DOCUSATE SODIUM, Capsule, 250 mg, NDC 00536375701, Pedigree: W003358, EXP: 6/19/2014.
Code information LISINOPRIL Tablet, 2.5 mg has the following codes Pedigree: AD25264_4, EXP: 5/3/2014; Pedigree: W003365, EXP: 6/19/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[1614]
FDA event record
· Exact recall-number query on openFDA
Recall number D-693-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 100 Capsules
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; ZONISAMIDE Capsule, 100 mg may be potentially mislabeled as PHYTONADIONE, Tablet, 5 mg, NDC 25010040515, Pedigree: W003737, EXP: 5/31/2014.
Code information ZONISAMIDE Capsule, 100 mg has the following code Pedigree: W003786, EXP: 6/27/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[2750]
FDA event record
· Exact recall-number query on openFDA
Recall number D-694-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 100 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; METAXALONE Tablet, 800 mg may be potentially mislabeled as ESTERIFIED ESTROGENS, Tablet, 0.625 mg, NDC 61570007301, Pedigree: W003736, EXP: 6/26/2014.
Code information METAXALONE Tablet, 800 mg has the following code Pedigree: W003738, EXP: 6/26/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[1822]
FDA event record
· Exact recall-number query on openFDA
Recall number D-695-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 100 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; HYDROCORTISONE Tablet, 5 mg may be potentially mislabeled as ORPHENADRINE CITRATE ER, Tablet, 100 mg, NDC 43386048024, Pedigree: W002962, EXP: 6/11/2014; CALCIUM ACETATE, Capsule, 667 mg, NDC 00054008826, Pedigree: W003045, EXP: 6/12/2014.
Code information HYDROCORTISONE Tablet, 5 mg has the following codes Pedigree: W002966, EXP: 6/11/2014; Pedigree: W003046, EXP: 6/12/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[2842]
FDA event record
· Exact recall-number query on openFDA
Recall number D-696-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 150 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; COLCHICINE Tablet, 0.6 mg may be potentially mislabeled as CHOLECALCIFEROL, Tablet, 2000 units, NDC 00904615760, Pedigree: AD46312_37, EXP: 5/16/2014; PSEUDOEPHEDRINE HCL, Tablet, 30 mg, NDC 00904505360, Pedigree: AD52993_37, EXP: 5/20/2014; SENNOSIDES, Tablet, 8.6 mg, NDC 00182109301, Pedigree: AD62992_14, EXP: 5/23/2014; CHOLECALCIFEROL, Tablet, 1000 units, NDC 00904
Code information COLCHICINE Tablet, 0.6 mg has the following codes Pedigree: AD46419_1, EXP: 5/16/2014; Pedigree: AD52778_22, EXP: 5/20/2014; Pedigree: AD65457_1, EXP: 5/23/2014; Pedigree: W003612, EXP: 6/25/2014; Pedigree: W002961, EXP: 6/11/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[2708]
FDA event record
· Exact recall-number query on openFDA
Recall number D-697-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 180 Capsules
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; LUBIPROSTONE Capsule, 24 mcg may be potentially mislabeled as ARIPiprazole, Tablet, 2 mg, NDC 59148000613, Pedigree: AD21790_43, EXP: 5/1/2014; CYANOCOBALAMIN, Tablet, 1000 mcg, NDC 00904421713, Pedigree: AD21846_46, EXP: 5/1/2014; VALSARTAN, Tablet, 160 mg, NDC 00078035934, Pedigree: AD39858_1, EXP: 5/16/2014.
Code information LUBIPROSTONE Capsule, 24 mcg has the following codes Pedigree: AD21790_46, EXP: 5/1/2014; Pedigree: AD21811_1, EXP: 5/1/2014; Pedigree: AD46312_1, EXP: 5/16/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[2829]
FDA event record
· Exact recall-number query on openFDA
Recall number D-698-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 300 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; FEBUXOSTAT Tablet, 40 mg may be potentially mislabeled as methylPREDNISolone, Tablet, 4 mg, NDC 59746000103, Pedigree: AD21811_17, EXP: 5/1/2014; tiZANidine HCl, Tablet, 2 mg, NDC 55111017915, Pedigree: W002663, EXP: 6/5/2014; SODIUM CHLORIDE, Tablet, 1000 mg, NDC 00527111610, Pedigree: W003926, EXP: 7/1/2014.
Code information FEBUXOSTAT Tablet, 40 mg has the following codes Pedigree: AD23082_16, EXP: 11/1/2013; Pedigree: W002664, EXP: 6/5/2014; Pedigree: W003927, EXP: 7/1/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[4090]
FDA event record
· Exact recall-number query on openFDA
Recall number D-699-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 1,000 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; PHOSPHORUS Tablet, 250 mg may be potentially mislabeled as CITALOPRAM, Tablet, 10 mg, NDC 57664050788, Pedigree: AD56921_1, EXP: 5/21/2014; VENLAFAXINE HCL, Tablet, 75 mg, NDC 00093738201, Pedigree: W002533, EXP: 2/28/2014; NITROFURANTOIN MACROCRYSTALS, Capsule, 50 mg, NDC 47781030701, Pedigree: AD25452_4, EXP: 5/3/2014; traZODone HCl, Tablet, 50 mg, NDC 50111043303, P
Code information PHOSPHORUS Tablet, 250 mg has the following codes Pedigree: AD56916_1, EXP: 5/21/2014; Pedigree: W002534, EXP: 6/3/2014; Pedigree: AD25452_7, EXP: 5/3/2014; Pedigree: AD54498_1, EXP: 5/20/2014; Pedigree: W003997, EXP: 7/1/2014; Pedigree: AD46300_8, EXP: 5/15/2014; Pedigree: AD70639_10, EXP: 5/29/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[3617]
FDA event record
· Exact recall-number query on openFDA
Recall number D-700-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 1,249 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; LACTOBACILLUS Tablet may be potentially mislabeled as MULTIVITAMIN/MULTIMINERAL, Tablet, NDC 65162066850, Pedigree: AD62979_1, EXP: 5/23/2014; CALCIUM ACETATE, Capsule, 667 mg, NDC 00054008826, Pedigree: AD62986_1, EXP: 5/23/2014; LITHIUM CARBONATE ER, Tablet, 225 mg (1/2 of 450 mg), NDC 00054002025, Pedigree: AD21790_25, EXP: 5/1/2014; OMEGA-3 FATTY ACID, Capsule, 100
Code information LACTOBACILLUS Tablet has the following codes Pedigree: AD62986_10, EXP: 5/23/2014; Pedigree: AD62992_1, EXP: 5/23/2014; Pedigree: AD22865_1, EXP: 5/2/2014; Pedigree: W003624, EXP: 1/31/2014; Pedigree: W003622, EXP: 6/25/2014; Pedigree: W003623, EXP: 10/31/2013.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[2786]
FDA event record
· Exact recall-number query on openFDA
Recall number D-701-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 509 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; CHOLECALCIFEROL/CALCIUM/PHOSPHORUS Tablet, 120 units/105 mg/81 mg may be potentially mislabeled as PROMETHAZINE HCL, Tablet, 25 mg, NDC 65162052110, Pedigree: W002578, EXP: 6/3/2014; VALSARTAN, Tablet, 40 mg, NDC 00078042315, Pedigree: AD32579_1, EXP: 5/9/2014.
Code information CHOLECALCIFEROL/CALCIUM/PHOSPHORUS Tablet, 120 units/105 mg/81 mg has the following codes Pedigree: W002581, EXP: 6/3/2014; Pedigree: AD32345_1, EXP: 5/14/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[2728]
FDA event record
· Exact recall-number query on openFDA
Recall number D-702-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 200 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; aMILoride HCl Tablet, 5 mg may be potentially mislabeled as PROPRANOLOL HCL, Tablet, 10 mg, NDC 23155011001, Pedigree: AD60272_37, EXP: 5/22/2014; FAMOTIDINE, Tablet, 20 mg, NDC 16714036104, Pedigree: W003764, EXP: 6/26/2014.
Code information aMILoride HC, Tablet, 5 mg has the following codes Pedigree: AD60272_55, EXP: 5/22/2014; Pedigree: W003686, EXP: 6/26/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[3885]
FDA event record
· Exact recall-number query on openFDA
Recall number D-703-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 100 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; DISULFIRAM Tablet, 250 mg may be potentially mislabeled as PYRIDOXINE HCL, Tablet, 50 mg, NDC 00904052060, Pedigree: AD22865_22, EXP: 5/2/2014.
Code information DISULFIRAM Tablet, 250 mg has the following code Pedigree: AD22609_1, EXP: 5/2/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[3452]
FDA event record
· Exact recall-number query on openFDA
Recall number D-704-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 1,013 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; SODIUM BICARBONATE Tablet, 650 mg may be potentially mislabeled as NICOTINE POLACRILEX, Lozenge, 2 mg, NDC 00135051001, Pedigree: W002974, EXP: 6/11/2014.
Code information SODIUM BICARBONATE Tablet, 650 mg has the following code Pedigree: W002970, EXP: 6/11/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[2827]
FDA event record
· Exact recall-number query on openFDA
Recall number D-705-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 240 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling: Label Mixup; RILUZOLE Tablet, 50 mg may be potentially mislabeled as traZODone HCl, Tablet, 150 mg, NDC 50111044101, Pedigree: W003245, EXP: 6/17/2014.
Code information RILUZOLE Tablet, 50 mg has the following code Pedigree: W003255, EXP: 6/17/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[2783]
FDA event record
· Exact recall-number query on openFDA
Recall number D-706-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 1,000 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling:Label Mixup; FOLIC ACID, Tablet, 1 mg may be potentially mislabeled as OMEGA-3 FATTY ACID, Capsule, 1000 mg, NDC 00904404360, Pedigree: AD32328_5, EXP: 5/9/2014; DOCUSATE CALCIUM, Capsule, 240 mg, NDC 00536375501, Pedigree: W003821, EXP: 6/27/2014; ATORVASTATIN CALCIUM, Tablet, 40 mg, NDC 00378212177, Pedigree: W003096, EXP: 6/13/2014.
Code information FOLIC ACID, Tablet, 1 mg has the following codes Pedigree: AD33897_22, EXP: 5/9/2014; Pedigree: W003822, EXP: 6/27/2014; Pedigree: W003097, EXP: 6/13/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[3563]
FDA event record
· Exact recall-number query on openFDA
Recall number D-707-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 100 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling:Label Mixup; PROMETHAZINE HCL, Tablet, 25 mg may be potentially mislabeled as CHOLECALCIFEROL, Tablet, 400 units, NDC 00904582360, Pedigree: W002574, EXP: 6/3/2014.
Code information PROMETHAZINE HCL, Tablet, 25 mg has the following code Pedigree: W002578, EXP: 6/3/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[3889]
FDA event record
· Exact recall-number query on openFDA
Recall number D-708-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 100 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling:Label Mixup; FLECAINIDE ACETATE Tablet, 50 mg may be potentially mislabeled as VITAMIN B COMPLEX W/C, Tablet, NDC 00904026013, Pedigree: AD46419_7, EXP: 5/16/2014.
Code information FLECAINIDE ACETATE Tablet, 50 mg has the following code Pedigree: AD46414_16, EXP: 5/16/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[3466]
FDA event record
· Exact recall-number query on openFDA
Recall number D-709-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 200 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling:Label Mixup; MULTIVITAMIN/MULTIMINERAL Tablet may be potentially mislabeled as PRENATAL MULTIVITAMIN/MULTIMINERAL Tablet, NDC 00904531360, Pedigree: AD73652_16, EXP: 5/30/2014.
Code information MULTIVITAMIN/MULTIMINERAL Tablet has the following code Pedigree: AD73646_13, EXP: 5/30/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[1258]
FDA event record
· Exact recall-number query on openFDA
Recall number D-710-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 1,000 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling:Label Mixup; MULTIVITAMIN/MULTIMINERAL Tablet may be potentially mislabeled as OMEGA-3 FATTY ACID, Capsule, 1000 mg, NDC 00904404360, Pedigree: AD62865_13, EXP: 5/23/2014; guaiFENesin ER, Tablet, 600 mg, NDC 63824000834, Pedigree: W003514, EXP: 6/21/2014.
Code information MULTIVITAMIN/MULTIMINERAL Tablet has the following codes Pedigree: AD62979_1, EXP: 5/23/2014; Pedigree: W003553, EXP: 6/24/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[2761]
FDA event record
· Exact recall-number query on openFDA
Recall number D-711-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 501 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling:Label Mixup; guanFACINE HCl Tablet, 2 mg may be potentially mislabeled as buPROPion HCl ER, Tablet, 200 mg, NDC 47335073886, Pedigree: AD21790_4, EXP: 5/1/2014; AMANTADINE HCL, Capsule, 100 mg, NDC 00781204801, Pedigree: W002997, EXP: 6/11/2014; glyBURIDE, Tablet, 1.25 mg, NDC 00093834201, Pedigree: W003677, EXP: 2/28/2014; ACYCLOVIR, Capsule, 200 mg, NDC 00093894001, Pedigree: AD60
Code information guanFACINE HCl Tablet, 2 mg has the following codes Pedigree: AD21790_13, EXP: 5/1/2014; Pedigree: W002999, EXP: 6/11/2014; Pedigree: W003678, EXP: 6/25/2014; Pedigree: AD60272_10, EXP: 5/22/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[2778]
FDA event record
· Exact recall-number query on openFDA
Recall number D-712-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 100 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling:Label Mixup; BENAZEPRIL HCL Tablet, 5 mg may be potentially mislabeled as ZINC SULFATE, Capsule, 220 mg, NDC 60258013101, Pedigree: AD52993_34, EXP: 5/20/2014.
Code information BENAZEPRIL HCL Tablet, 5 mg has the following code Pedigree: AD52778_7, EXP: 5/20/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[3624]
FDA event record
· Exact recall-number query on openFDA
Recall number D-713-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 799 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling:Label Mixup; BENAZEPRIL HCL Tablet, 40 mg may be potentially mislabeled as NEFAZODONE HCL, Tablet, 200 mg, NDC 00093102506, Pedigree: AD46414_44, EXP: 5/16/2014; guaiFENesin ER, Tablet, 600 mg, NDC 63824000834, Pedigree: W003931, EXP: 6/28/2014; CALCIUM ACETATE, Capsule, 667 mg, NDC 00054008826, Pedigree: AD42592_1, EXP: 5/14/2014; ACETAMINOPHEN/ ASPIRIN/ CAFFEINE, Tablet, 250 mg/25
Code information BENAZEPRIL HCL Tablet, 40 mg has the following codes Pedigree: AD49423_1, EXP: 5/16/2014; Pedigree: W003918, EXP: 6/28/2014; Pedigree: AD32757_7, EXP: 5/13/2014; Pedigree: AD68010_1, EXP: 5/28/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[3630]
FDA event record
· Exact recall-number query on openFDA
Recall number D-714-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 180 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling:Label Mixup; COLESEVELAM HCL Tablet, 625 mg may be potentially mislabeled as lamoTRIgine Tablet, 50 mg (1/2 of 100 mg), NDC 13668004701, Pedigree: AD46265_31, EXP: 5/15/2014.
Code information COLESEVELAM HCL Tablet, 625 mg has the following code Pedigree: AD46426_19, EXP: 5/15/2014
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[2746]
FDA event record
· Exact recall-number query on openFDA
Recall number D-715-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 30 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling:Label Mixup; rifAXIMin Tablet, 200 mg may be potentially mislabeled as CapsuleTOPRIL, Tablet, 25 mg, NDC 00143117201, Pedigree: AD52778_19, EXP: 5/20/2014.
Code information rifAXIMin Tablet, 200 mg has the following code Pedigree: AD54587_10, EXP: 4/30/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[4120]
FDA event record
· Exact recall-number query on openFDA
Recall number D-716-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 400 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling:Label Mixup; QUEtiapine FUMARATE, Tablet, 25 mg may be potentially mislabeled as chlordiazePOXIDE HCl, Capsule, 25 mg, NDC 00555015902, Pedigree: AD49426_1, EXP: 5/16/2014.
Code information QUEtiapine FUMARATE, Tablet, 25 mg has the following code Pedigree: AD49582_22, EXP: 4/30/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[2845]
FDA event record
· Exact recall-number query on openFDA
Recall number D-717-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 60 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling:Label Mixup; IRBESARTAN, Tablet, 150 mg may be potentially mislabeled as ATROPINE SULFATE/DIPHENOXYLATE HCL, Tablet, 0.025 mg/2.5 mg, NDC 00378041501, Pedigree: W003597, EXP: 6/24/2014; CHOLECALCIFEROL, Tablet, 400 units, NDC 00904582360, Pedigree: AD76686_7, EXP: 5/31/2014.
Code information IRBESARTAN, Tablet, 150 mg has the following codes Pedigree: W003649, EXP: 6/25/2014; Pedigree: AD73686_7, EXP: 5/31/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[4081]
FDA event record
· Exact recall-number query on openFDA
Recall number D-718-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 100 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling:Label Mixup; PHENobarbital/ HYOSCYAMINE/ ATROPINE/ SCOPOLAMINE, Tablet, 16.2 mg/0.1037 mg/0.0194 mg/0.0065 mg may be potentially mislabeled as VALSARTAN, Tablet, 160 mg, NDC 00078035934, Pedigree: W003639, EXP: 6/25/2014.
Code information PHENobarbital/ HYOSCYAMINE/ ATROPINE/ SCOPOLAMINE, Tablet, 16.2 mg/0.1037 mg/0.0194 mg/0.0065 mg has the following code Pedigree: W003640, EXP: 6/25/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[4068]
FDA event record
· Exact recall-number query on openFDA
Recall number D-719-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 229 Capsules
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling:Label Mixup; carBAMazepine ER, Capsule, 200 mg may be potentially mislabeled as ACAMPROSATE CALCIUM DR, Tablet, 333 mg, NDC 00456333001, Pedigree: AD46333_1, EXP: 5/15/2014.
Code information carBAMazepine ER, Capsule, 200 mg has the following code Pedigree: AD32764_14, EXP: 5/14/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[4078]
FDA event record
· Exact recall-number query on openFDA
Recall number D-720-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 60 Capsules
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling:Label Mixup; SELEGILINE HCL, Capsule, 5 mg may be potentially mislabeled as ITRACONAZOLE, Capsule, 100 mg, NDC 10147170003, Pedigree: AD54549_10, EXP: 5/20/2014.
Code information SELEGILINE HCL, Capsule, 5 mg has the following code Pedigree: AD54549_19, EXP: 5/20/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[1853]
FDA event record
· Exact recall-number query on openFDA
Recall number D-721-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 181 Capsules
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling:Label Mixup; DOCUSATE SODIUM, Capsule, 50 mg may be potentially mislabeled as LEVOTHYROXINE SODIUM, Tablet, 112 mcg, NDC 00378181101, Pedigree: AD60211_1, EXP: 5/21/2014; MEXILETINE HCL, Capsule, 150 mg, NDC 00093873901, Pedigree: AD62865_7, EXP: 5/23/2014; CHOLECALCIFEROL, Tablet, 5000 units, NDC 00761017840, Pedigree: AD65457_10, EXP: 5/24/2014.
Code information DOCUSATE SODIUM, Capsule, 50 mg has the following codes Pedigree: AD60211_8, EXP: 5/21/2014; Pedigree: AD62865_10, EXP: 5/23/2014; Pedigree: AD65457_13, EXP: 5/24/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[1859]
FDA event record
· Exact recall-number query on openFDA
Recall number D-722-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 60 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling:Label Mixup; buPROPion HCl ER (XL), Tablet, 150 mg may be potentially mislabeled as MESALAMINE CR, Capsule, 250 mg, NDC 54092018981, Pedigree: AD52412_1, EXP: 5/17/2014.
Code information buPROPion HCl ER (XL), Tablet, 150 mg has the following code Pedigree: AD52412_4, EXP: 4/30/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[2769]
FDA event record
· Exact recall-number query on openFDA
Recall number D-723-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 200 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling:Label Mixup; IBUPROFEN, Tablet, 400 mg may be potentially mislabeled as ASPIRIN, Tablet, 325 mg, NDC 00536330501, Pedigree: W002573, EXP: 6/3/2014.
Code information IBUPROFEN, Tablet, 400 mg has the following code Pedigree: W002577, EXP: 6/3/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[2760]
FDA event record
· Exact recall-number query on openFDA
Recall number D-724-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 90 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling:Label Mixup; QUINAPRIL HCL, Tablet, 20 mg may be potentially mislabeled as MULTIVITAMIN/MULTIMINERAL, Tablet, NDC 65162066850, Pedigree: W003553, EXP: 6/24/2014.
Code information QUINAPRIL HCL, Tablet, 20 mg has the following code Pedigree: W003556, EXP: 6/24/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[3940]
FDA event record
· Exact recall-number query on openFDA
Recall number D-725-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 200 Capsules
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling:Label Mixup; RAMIPRIL, Capsule, 2.5 mg, Rx only may be potentially mislabeled as PROPAFENONE HCL, Tablet, 150 mg, NDC 00591058201, Pedigree: AD54549_13, EXP: 5/20/2014; CALCIUM POLYCARBOPHIL, Tablet, 625 mg, NDC 00536430611, Pedigree: AD73592_11, EXP: 5/31/2014.
Code information RAMIPRIL, Capsule, 2.5 mg, Rx only has the following codes Pedigree: AD54549_16, EXP: 5/20/2014; Pedigree: AD76639_1, EXP: 5/31/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[3558]
FDA event record
· Exact recall-number query on openFDA
Recall number D-726-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 90 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling:Label Mixup; amLODIPine BESYLATE, Tablet, 10 mg may be potentially mislabeled as FINASTERIDE, Tablet, 5 mg, NDC 16714052201, Pedigree: AD62846_1, EXP: 2/28/2014.
Code information amLODIPine BESYLATE, Tablet, 10 mg has the following code Pedigree: AD62846_4, EXP: 5/24/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[2780]
FDA event record
· Exact recall-number query on openFDA
Recall number D-727-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 168 Capsules
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling:Label Mixup; RIBAVIRIN, Capsule, 200 mg may be potentially mislabeled as MODAFINIL, Tablet, 50 mg (1/2 of 100 MG Tablet), NDC 55253080130, Pedigree: AD21787_4, EXP: 5/1/2014; DESIPRAMINE HCL, Tablet, 50 mg, NDC 45963034302, Pedigree: AD30140_7, EXP: 5/7/2014.
Code information RIBAVIRIN, Capsule, 200 mg has the following codes Pedigree: AD21790_37, EXP: 4/30/2014; Pedigree: AD30140_13, EXP: 4/30/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[2797]
FDA event record
· Exact recall-number query on openFDA
Recall number D-728-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 29 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling:Label Mixup; FLUCONAZOLE, Tablet, 50 mg may be potentially mislabeled as FLUCONAZOLE, Tablet, 200 mg, NDC 00172541360, Pedigree: W003065, EXP: 6/12/2014.
Code information FLUCONAZOLE, Tablet, 50 mg has the following code Pedigree: W003066, EXP: 6/12/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[4100]
FDA event record
· Exact recall-number query on openFDA
Recall number D-729-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 30 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling:Label Mixup; FLUCONAZOLE, Tablet, 100 mg may be potentially mislabeled as PRENATAL MULTIVITAMIN/ MULTIMINERAL, Tablet, NDC 51991056601, Pedigree: W003086, EXP: 6/12/2014.
Code information FLUCONAZOLE, Tablet, 100 mg has the following code Pedigree: W003064, EXP: 6/12/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[3622]
FDA event record
· Exact recall-number query on openFDA
Recall number D-730-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 100 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling:Label Mixup; VERAPAMIL HCL ER, Tablet, 240 mg may be potentially mislabeled as TRIFLUOPERAZINE HCL, Tablet, 1 mg, NDC 00781103001, Pedigree: AD52778_91, EXP: 5/21/2014.
Code information VERAPAMIL HCL ER, Tablet, 240 mg has the following code Pedigree: AD52778_94, EXP: 5/21/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[4058]
FDA event record
· Exact recall-number query on openFDA
Recall number D-731-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 90 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling:Label Mixup; PRAMIPEXOLE DI-HCL, Tablet, 1.5 mg may be potentially mislabeled as LIOTHYRONINE SODIUM, Tablet, 25 mcg, NDC 42794001902, Pedigree: AD68010_11, EXP: 5/28/2014.
Code information PRAMIPEXOLE DI-HCL, Tablet, 1.5 mg has the following code Pedigree: AD68010_20, EXP: 5/28/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[2843]
FDA event record
· Exact recall-number query on openFDA
Recall number D-732-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 30 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling:Label Mixup; RASAGILINE MESYLATE, Tablet, 0.5 mg may be potentially mislabeled as OMEGA-3 FATTY ACID, Capsule, 1000 mg, NDC 40985022921, Pedigree: W002690, EXP: 6/5/2014.
Code information RASAGILINE MESYLATE, Tablet, 0.5 mg has the following code Pedigree: W002929, EXP: 6/10/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[3480]
FDA event record
· Exact recall-number query on openFDA
Recall number D-733-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 720 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling:Label Mixup; MAGNESIUM CHLORIDE, Tablet, 64 mg may be potentially mislabeled as VITAMIN B COMPLEX W/C, Tablet, NDC 00904026013, Pedigree: AD52993_31, EXP: 5/17/2014; ASPIRIN EC, Tablet, 325 mg, NDC 00904201360, Pedigree: W003526, EXP: 6/21/2014; NICOTINE POLACRILEX, LOZENGE, 2 mg, NDC 00135051001, Pedigree: W002766, EXP: 6/6/2014; THIAMINE HCL, Tablet, 100 mg, NDC 00904054460, Pedig
Code information MAGNESIUM CHLORIDE, Tablet, 64 mg has the following codes Pedigree: AD52993_4, EXP: 5/17/2014; Pedigree: W003527, EXP: 6/21/2014; Pedigree: W002712, EXP: 6/6/2014; Pedigree: W003359, EXP: 6/19/2014; Pedigree: W003923, EXP: 6/28/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[1246]
FDA event record
· Exact recall-number query on openFDA
Recall number D-734-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 360 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling:Label Mixup; MELATONIN, Tablet, 1 mg may be potentially mislabeled as OMEGA-3 FATTY ACID, Capsule, 1000 mg, NDC 40985022921, Pedigree: W003711, EXP: 6/26/2014.
Code information MELATONIN, Tablet, 1 mg has the following code Pedigree: W003717, EXP: 6/26/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[1867]
FDA event record
· Exact recall-number query on openFDA
Recall number D-735-2014
Initiated July 02, 2013
Classification Class II
Status Terminated
Quantity 200 Tablets
App-derived interpretation
Labeling or packaging
reason.labeling_packaging · v1.0.0
mislabeled
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Labeling:Label Mixup; HYOSCYAMINE SULFATE SL Tablet, 0.125 mg may be potentially mislabeled as azaTHIOprine, Tablet, 50 mg, NDC 00054408425, Pedigree: AD56832_1, EXP: 5/21/2014; CHOLECALCIFEROL, Tablet, 1000 units, NDC 00904582460, Pedigree: W003464, EXP: 6/20/2014.
Code information HYOSCYAMINE SULFATE SL, Tablet, 0.125 mg has the following codes Pedigree: AD54501_1, EXP: 5/21/2014; Pedigree: W003438, EXP: 6/20/2014.
Distribution pattern Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[4086]
FDA event record
· Exact recall-number query on openFDA